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SUMMARY 
In the INTRODUCTION (ch. 1) the three elements which make up the title of this 
thesis will be treated briefly. In doing so the central problem will be presented. 
namelv. "what biochemical mechanism is responsible for the epileptogenic actions 
of folic acid9" 
In the PROMENADES we explam the approach to the central problem of the 
thesis and the connections between the various chapters. Please refer to these 
promenades foi a summnn' of the various chapters (¡n english or m dutch) 
In the CONCLUSION (ch. 9) new questions ansing from the results of the ex-
periments will be discussed These questions do not only concern the subject of 
this thesis, but deal with both the theorv of receptor-binding-studies m general 
and with the GABAA complex in particular as well. 
SAMENVATTING 
In de INLEIDING (hfdst 1) wordt op de dne begrippen die samen de titel van dit 
proefschnft vormen ingegaan Hierbij wordt ook de centrale vraagstelling die aan 
dit werk ten grondslag hgt gepresenteerd, namelijk "door welk biochemisch 
mechanisme is foliumzuur in staat om epileptogene verschijnselen te veroor-
zaken''". 
In de PROMENADES wordt de aanpak van de vraagstelling en de samenhang van 
de verschillende hoofdstukken toegelicht On het engels en in het nederlands). 
Voor een samenvatting van de afzonderlijke hoofdstukken verwijs ik и graag naar 
de promenades 
In de CONCLUSIE (hfdst. 9) worden nieuwe vragen die opgeroepen worden door 
de resultaten van de uitgevoerde experimenten aangestipt. Deze vragen hangen 
niet alleen samen met de vraagstelling in dit proefschrift, maar hebben ook 
betrekking op zowel de theorie van receptor-binding-studies in het algemeen als 
op het GABAA complex in hel bijzonder. 
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THE BLIND MEN AND THE ELEPHANT 
It was six men of Indostan 
To learning much inclined 
Who nent to îee the Elephant 
(Though all of them were blind), 
That each bv observation 
Might satisfy his mind 
The Fust approached the Elephant 
And happening to fall 
Against his broad and sturdv side 
At once began to haul 
"God bless me' but the Elephant 
ІЧ very like a wall'' 
The Second feeling of the tusk 
Cned "Ho' what have we here 
So ven' round and smooth and sharp0 
To me 'tis mightv clear 
This wonder of an Elephant 
Is very like a spear'" 
The Third approached the animal, 
And happening to take 
The sqiurmmg trunk within his hands 
Thus boldlv up and spake 
"I see " quoth he "the Elephant 
Is verv like a snake'' 
The Fourth reached out an eager hand 
And felt about the knee 
"What most this wondrous beast is like 
Is mighty plain " quoth he 
"'Tis clear enough the Elephant 
Is verv like a tree'" 
The Fifth who chanced to touch the ear 
Said 'E'en the blindest man 
Can tell what this resembles most, 
Denv the fact who can 
This marvel of an Elephant 
Is verv like a fan'" 
The Sixth no sooner had begun 
About the beast to grope, 
Than seizing on the swinging tail 
That fell witlun his scope. 
"I see " quoth he "the Elephant 
Is verv like a rope'" 
And so these men of Indostan 
Disputed loud and long 
Each m his own opinion 
Exceeding stiff and strong 
Though each was partly in the right 
And all were m the wrong' 
John Godfrey Saxe, 
Amencan Poet 1816-1887 

CHAPTER 1 INTRODUCTION 
1.1 EPILEPSY. 
Epilepsy In human is a common disorder affecting 6 25/1000 people [6) Epilepsy 
is not a clearlv defined disorder The term is considered to descnbe chronic brain 
syndromes of vanous etiology characterized by recurrent convulsive and non-
convulsive seizures due to excessive discharges of cerebral neurons attended with 
a vanetv of clinical manifestations [5, 32] 
The epilepsies may be divided into two main groups the generalized epilepsies and 
the partial or focal epilepsies 
- The generalized epilepsies are charactenzed bv an initial disturbance of 
consciousness accompanied with other symptoms such as convulsions or 
absences The EEG exhibits synchronous discharges from both hemispheres 
Partial epilepsies may exhibit localized symptoms of motoric sensorie 
autonomic or mental character attended with abnormalities on the EEG 
originating from a circumsenbed part of the brain The partial seizures may 
develop into generalized seizures 
In addition to the division desenbed above, epilepsy may be desenbed as idiopa-
thic or as symptomatic 
- Idiopathic epilepsy implies that the cause of the disorder is unknown 
- Symptomatic epilepsv is due to some demonstrable brain disease (e g con-
genital cerebral defects, intracranial or general infections, intoxications, 
cerebral tumors vascular disorders or cerebral degeneration) [12] 
Whether the epilepsies are due to a single common etiological cause is unknown 
[3, 6, 7] Aspects of possible etiological factors have been reviewed recently [3 
7] Only a start has been made to unravel the cellular and molecular mechanisms 
of the epilepsies Two systems are thought to be of particular importance m the 
epileptogenesis the inhibitory GABA system and the excitatory glutamate system 
[1, 8, 16, 17, IS, 23 29, 33, 34, 35] 
Animal models of epilepsy are of great importance to the search for the basic 
neuronal disfunction underlying the disease as well as to the search for new 
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effective antiepileptic drugs [9 14, 19, 20 26, 27 30] The animals mav be 
affected spontaneously or the seizures may be invoked by sensorie stimulation [2, 
4, 15, 22, 24, 25, 31] Moreover, epileptic phenomena can be induced m animals, 
e g by convulsive drugs, by electrical stimulation (by electroconvulsive shocks and 
by 'kindling') [11] Chemically, seizures are often induced by compounds alien to 
the body such as pentylenetetrazol (Cardiazole), penicillin and kamic acid [10, 13, 
21] Some endogenous substances can induce seizures as well eg glutamate, 
aspartate, and folic acid, all in high concentrations [3, 28] Glutamate and aspar­
tate are known excitatory neurotransmitters In contrast, the mechanism underly­
ing the epileptogenic effects of folic acid is not known 
In this thesis we desenbe our investigations on the mechanism of the epilep­
togenic action of folic acid In the studies described, an animal model of chemi­
cally induced, partial epilepsy with elementary motor symptoms is used 
1.2 FOLATES. 
Folates In general. 
Folic acid owes its name to its abundant presence in green leafy vegetables, 
especially spinach (folio means leave), but it is present in nearly all food substan­
ces [5] Folic acid is reduced in the body into a senes of denvatives [6] Folic 
acid and its denvatives are collectively called the folates Folates are needed in 
biological syntheses they are involved as coenzymes in nearly all those metabolic 
functions in which there is a transfer of one-carbon units 
Folates are commonly known because of 
- their role in megaloblastic anaemia due to their involvement in e g DNA 
synthesis [44] Adequate folate availability is a precondition for cell prolif­
eration [6] 
- the role of folate antimetabolites in cancer therapy [4] Methotrexate blocks 
dihydrofolate reductase, resulting m a depletion of reduced ι e metabohcally 
active folates 
- the bactenostatic properties of sulfonamides [54] Mammals do not syn­
thesize folic acid it is a vitamin Bactena must synthesize folic acid them-
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selves. This synthesis can be blocked by sulfonamides, which are antimetabo-
lites of paraaminobenzoic acid (PABA), which is one of the components of 
folic acid. 
In addition folates are able to induce epileptic phenomena when they have penet-
rated into the brain [26]. It is not likely that a mechanism associated with the 
one-carbon transfer properties of the folates can account for the epileptogenic 
effects, as the antimetabolite Methotrexate is able to induce convulsions as well 
[38, 39]. Methotrexate has no one-carbon transfer properties. 
Chemical structure of the folates. 
Folic acid (Pteroylglutamic acid, Vitamin Be, C19H19N7O6, Mol. wt 441), is 
composed of 2-amino-4-hydroxy-pteridine, paraaminobenzoic acid and glutamic 
acid [7]. (Structural formula see folder at the end of the thesis.) Folates are 
present in various metabolically active reduced forms, such as 5-formyl-tetra-
hydrofolate (S-HCO-H-ifolate), dihydrofolate (Fhfolate) and 5-methyl-tetra-
hydrofolate (S-CHa-IWolate). 
The most abundant form of folates in the body is that in which more than one 
glutamate unit is present in the molecule. The glutamate units are linked chainlike 
by amide bonds to the ¿'-carboxyl group of the preceding glutamate [35]. 
Folates In the central nervous system. 
In rats and in humans the concentration of folates in the CSF (cerebro-spinal 
fluid) is substantially higher than the concentration in plasma [8, 50. 59]. Reduced 
folates are transported from the blood into the CSF and oxidized folates are 
transported out of the CSF back into the blood by a carrier-mediated transport 
system located in the plexus chorioideus [21, 49, 55]. These transport processes 
at the blood-brain barrier help to maintain a reduced folate homeostasis in the 
brain. No oxidized folate (i.e. folic acid itself) was detected in brain tissue. 5-
Methyl-tetrahydrofolate and tetrahydrofolate are the predominantly occurring 
monoglutamate-folates in the (rat)brain. The monoglutamate-folates do not account 
for more than 10 % of the total folate pool in the brain. About 70 % of the 
endogenous folates in the brain of the rat are pentaglutamates or folates with 
greater chain length [10]. The available data of total folate concentrations should 
be interpreted with this in mind. 
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Folate concentrations 
Total folate Human serum 
CSF 
cortex grey 
cortex white 
liver 
serum 
bram 
liver 
cortex 
5 - 12 ng/ml 
1 4 - 3 1 ng/ml 
+ 400 ng/g ww 
± 200 ng/g ww 
3000 ng/g ww 
53 - 190 ng/ml 
360 630 ng/g ww 
12000 ng/g ww 
+ 44 ng/g ww 
[30] 
[ 8 ] 
[61] 
[61] 
[22] 
[ 6 ] 
[10] 
[20] 
[30] 
Total folate Rat 
5-CHi-H.i-folate Rat 
Folates and epilepsy. 
Interest in the convulsive action of folates was first raised by the observation of 
lowered folate serum levels in patients receiving anticonvulsant medication [3 8 
17 43, 44] It was hypothesized that the anticonvulsant action of the medication 
might result from a folate-lowenng effect, and thus that folate derivatives might 
have convulsive properties [11, 12, 37] In humans the proposed convulsive effect 
of folates, still the subject of many studies is neither proven nor dismissed [8 
32, 43, 45 60] In animals it has been shown that folate derivatives do indeed 
have convulsive activity [1 25 27, 28, 37, 51, 53] The biochemical mechanism of 
this activity is unknown 
With this thesis we hope to contnbute to the elucidation of this mechanism 
Synopsis of previous biochemical studies. 
A number of mechanisms have so far been proposed to underlie the convulsive 
action of the folates 
- A direct action of folates, probably on the GABA receptor was proposed in 
the early seventies [16, 24 51] It was not until 1985 that some electro-
physiological indications for this GABA-folate interaction hypothesis were 
published [42] 
- In the mean time folates have been reported to inhibit the high affimty 
uptake of glutamate [46], and to inhibit the uptake of a variety of neuro-
transmitters, GABA included, as well [9] 
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- Folates are able to inhibit the enzyme GAD (glutamate decarboxylase) [58] 
but the rank order of potency does not correlate with the epileptogenic 
actions (M G Ρ Feenstra, personal communication) 
- In 1980 it was reported that 5-methyl-tetrahydrofolate is a potent displacer 
of the glutaminergic compound ;lH-kaimc acid from its specific receptor sites 
[48] It was proposed that the folate derivative might be the endogenous 
hgand of the kainate receptor This would suggest that folates in the brain 
may function as excitatory neurotransmitters [23, 29, 52] This Finding 
however was not confirmed m other receptor binding studies [19], nor in 
electrophysiological studies [2, IS 19, 31, 36], nor in neurotoxicity studies 
[15 33 34, 40, 41, 47 56 57] 
As noted above a direct action of folates on the GABA receptor was suggested in 
1973 [16] Collmgndge indicated that folates increased the probabilitv of neuronal 
discharge [14] Clifford suggested that the mechanism of action of folates was 
more likely to be the result of disinhibition than of direct excitation [13] Otis, 
finally, showed that the application of folic acid to neurons results in a reduction 
of the GABA-mediated inhibitory postsynaptic potentials, and in a reduction of the 
response to lontophoretically applied GABA [42] These results suggest that folic 
acid exerts its action by a disinhibitorv mechanism, ι e bv antagonizing the 
postsynaptic action of GABA 
1 3 OABA RECEPTORS. 
Receptora in general 
Receptors may be defined as proteins to which a compound may bind reversibly, 
in such a way as to induce a conformational change m the protein which ul­
timately leads to a physiological response in the system Response inducing 
substances are called agonists Drugs that are able to bind to the receptor 
without inducing a response are called antagonists 
Neurotransmitter receptors are located in the plasma membrane of neurons They 
can be divided into two classes [36] 
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Class 1 The ligand-gated receptor ion channels These receptors induce a fast 
conductance change They do not need a second messenger system for 
this effect 
Class 2 Receptors coupled to a second messenger system and/or a G protein 
A number of neurotransmitter substances have been identified in the mammalian 
central nervous system Among these GABA is one of the most abundant [30] 
Anatomical studies suggest that GABA is predominantly located in small inter-
neurons scattered throughout the central nervous system [26] Agents capable of 
potentiating GABAergic transmission mav be expected to have a variety of biologi-
cal effects anticonvulsant, antidepressant, anxiolytic, hypnotic and analgetic 
effects have been reported [5, 7, 35] However apart from differences in anatomi-
cal location, this vanety of effects of GABAergic drugs may be due to neuro-
chemical differences one may think e g of differences in sensitivity of the GABA 
metabolizing enzymes Another possibility is that all GABA receptors may not be 
pharmacologically and functionally equivalent there may be distinct subgroups of 
GABA receptors which may be selectively manipulated At least two such sub-
groups are defined, and it is not likely that each group consists of a homogenous 
population [1, 2. 5, 13] 
- The GABAA receptors are linked to chloride channels such that receptor 
activation by GABA leads in general to an inward movement of Cl--ions, 
resulting m a hyperpolanzation (i e inhibition) of the postsynaptic cell The 
GABAA receptors belong to the class 1 receptors Bicuculhne antagonizes 
this action of GABA, whereas muscimol mimics it Baclofen has no effect on 
these GABAA receptors 
- The GABAB receptors activation of these receptors by GABA is thought to 
lead to a reduction of evoked excitatory neurotransmitter release resulting 
in a decreased excitation of the postsynaptic cell [5] GABAB receptors 
belong to the class 2 leceptors as they modulate adenylatecvclase activitv 
via an interaction with a GTP binding protein [38] These receptors are 
activated by (-)-Baclofen and GABA Bicuculhne does not bind to the GABAB 
receptors 
The receptor binding studies descnbed in this thesis are concerned exclusively 
with the GABAA receptor complex of the rat brain 
8 
Introduction 
The GABAA-receptor-complex-Cl-channel. 
See figure 1 (next page) and the folder at the end of the thesis 
Pharmacological and hgand binding studies have identified a number of binding 
sites on the GABAA receptor complex 
- The GABA agomst/antagomst site [5, 30. 31 36 55] This site is hkelv to be 
heterogeneous [3, 11, 21, 42] 
- The benzodiazepine site, which may be heterogeneous too [25 36, 42, 47] 
- The convulsant or channel gating site where agents like Picrotoxin and 
TBOB (t-butylbicycloorthobenzoate) will bind [15, 34, 43, 52] Probably this 
site is heterogenous as well [32, 49] 
- The depressant site, recognizing barbiturates [53] 
- Sites binding the channel-permeating anions [10, 36] 
Each of these tvpes of hgand sites can interact allostencally with one or more of 
the other sites, resulting in a network of interactions [3, 4, 9, 17 19 20, 22, 23, 
29, 40, 50, 51 54] 
Recently, the protein structure of the complex has been determined [1, 14, 41] 
The complex consists of two subumts α and β, with a stoichiometrv of агрг The 
a units cany the benzodiazepine recognition sites, whereas the GABA recognition 
sites are located on the β units The α subunit alone exists in at least three 
different vaneties [IS] This finding confirms the heterogeneous nature of the 
receptor/Cl" channel complex Both binding sites for GABA must be occupied 
with agonists in order to induce channel opening [47, 48] Binding of ligands to 
the benzodiazepine site influences the frequency of channel opening induced by 
GABA Benzodiazepine agomsts increase the action of GABA, inverse agonists 
decrease the influence of GABA [16, 27, 28] Binding of agents to the convulsant 
site blocks the GABA-activated channel, whereas binding of agonistic ligands to 
the depressant site prolongs the duration of aperture-opening of the GABA-
activated channel [5, 33] 
In addition to the hgand-receptor interactions named so far, some other effects 
on the complex have been described 
- A number of compounds with diverse chemical structures have been shown to 
modulate the GABA receptor function [8, 12, 44, 45, 46] Alcohols, a number 
of anaesthetics (e g etomidate) and steroids (e g progesterone) all affect the 
GABAA receptor function [6, 24, 33] Several compounds which are known 
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noncompetitive blockers of other class 1 receptors (the nicotinic acetyl­
choline receptor and the N methyl-d-aspartate subtype of the glutamate 
receptor) also inhibit the GABA gated CI- channel (e g phencvclidine D-
tubocuranne) [37] 
- The presence of membrane phospholipids and the nature of the receptor-
membrane interactions are essential to the integrity of the convulsant site 
[36, 39] 
In summary the GABAA-receptor-complex-Cl- channel is an ohgomenc membrane-
bound protein complex with allostenc and modulatory sites 
Figi The GABAA receptor complex: 
The conti ol of the Cl~ channels has been represented bv a revolving tap 
mechanism Binding 'Utes 
OABA and GABA agonists rotate the 'tap' into the open position, whereas 
GABA antagonists oppose this wtation The effects of drugs which affect the 
channel mechanism but which do not act at the GABA recognition site are 
represented bv adjacent wheels These wheels mav be considered as allostenc 
sites 
- In the model, the influence of the benzodiazepine agonists, ι e an increase 
m the frequencv with which the G ¿KB A-operated Ct channels open, is 
repiesented by an increase m the rate at which the channel wheel rotates 
caused bv an adjacent wheel 
- Ihe cogwheel represents the convulsant binding site Лея convulsants bmd 
to this site the lotation produced prevents the GABA induced increase m Ct 
conductance 
The influence of the convulsants may depend on the external Ctconcentra-
tion and this action is represented bv the pivot-lever 
- The influence of barbiturates has been represented by a 'latch' mechanism 
which on activation keeps the channel m open position 
(Reproduced (modifìed) from NG Bowery, et al, Neurophamìacology, 23 (19S4) 
219-211, with permission) 
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The research described m this thesis deals with the biochemical mechanism of the 
epileptogenic action of folic acid and its derivatives Two different experimental 
approaches were used 
- m vivo intracerebral application of convulsants m the rat 
- m vitro receptor binding awavs on rat brain membranes 
The m vivo sfud/es are presented in Part 1 of this thesis (chapters 2, 3. and 4) 
whereas Part 2 contains the m vitro investigations (chapters 5 6, 7 and S) 
Conclusions on the possible relationship between the m vivo and m vitro effects 
of the folates are discussed m chapter 9 
In the following paragraphs of this PROMFNADF the various chapters are briefly 
highlighted to show the interrelationship between the subject·; and the develop-
ment of our mvestigations 
Part 1: ID vivo: Chapters 2,3,4. 
The aim ot Ik? investigations presented ¡n this part was to answer the following 
questions 
1) Does folic acid, when injected into the neocortex, 
induce the same clinical course and electrophysiological 
semiology as (classes of) convulsants with better known 
mechanisms of action? 
Phenomena caused bv folic acid injection are compared to the effects of kamic 
acid, carbachol, neostigmine bicucullme penicillin and '¡trychmne (chapter 2) In 
chapter 3 seizures induced by baclofen are reported It turned out that m the 
neocortex folic acid epilepsy is comparable to that induced bv OABAeigic inhibito-
ry compounds, especially Picrotoxin and bicuculhne On the basis of this result we 
developed the hypothesis that folic acid might have a OABAergic inhibitorv action 
As it is known that the part of the prepmform cortex known as "area tempestas" 
(region of storms) is verv sensitive to bicuculhne, we considered the comparison 
of folic acid to bicucullme in this area to be a good test for the resemblance of 
the two drugs The next question was therefore 
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2) Will the pattern of epileptogenidty as observed in the 
neocortex be found in the 'area tempestas" as well? 
The convulsive effects of folic acid, bicuculhne and kainic acid injected into the 
prepinform cortex are descnbed and compaied (chapter 4) 
Part 2 In vitro: Chapters 5,6,7,8. 
Starting point for the m vitro studies descnbed in part 2 of this thesis was the 
GABAergic inhibiting mechanism of the substances mimicking folic acid m the 
neocortex Our aim therefore was to answer the following questions 
3) Do folates affect the ОАВАл complex in such a way as 
to account for the epileptogenic phenomena? 
The effects of four folates on three different binding sites on the OABAA recep­
tor complex were investigated (viz the high affmity GABA binding site, the 
benzodiazepine binding site and the convulsant site) and compared to the ability 
of the folates to induce epileptic phenomena m vivo (chapter 6) An enhancement 
of the binding of3H-TBOB to the convulsant site was found 
Ач the radiohgand 3H-TBOB was only recently introduced, we have included ui 
the precedmg chapter 5 our determination of the binding characteristics of this 
radioligand 
The enhancement of JH-TBOB bindmg by the folates led us to try to answer the 
following questions 
4) What Is the mechanism of the enhancement of the 
binding of3H-TBOB by folates? 
The influence of fohc acid on the binding of the convulsant 3H-TBOB is the 
subject of chapter 7 
5) What is the site of interaction of the folates with the 
ОАВАл complex? 
In chapter 8 the m vitro effects of the folates, bicuculhne and ßCCE are com-
pared 
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PROMENADE 1 NEDERLANDS 
Het onderzoek dat m dit proefschrift beschreven wordt betreft het biochemisch 
mechanisme dat ten grondslag ligt a,in de epileptogene werking van folium/uui en 
zijn derivaten Fr werden twee expenmentele opzetten gebruikt 
- m wvo mtraceiebrale toediening van convulïievc stoffen m de rat 
- m vitro receptor-binding-studie'; aan membranen van rattehenenen 
De m vivo studie·! worden beschieven m deel 1 vdn dit proefschnlt (hoofdstukken 
2 3 en 4) Deel twee bevat de in vitio studies (hoofdstukken 5, 6, 7 en S) Een 
mogelijke relatie tussen de m vivo en m vitro effecten wordt o a bespioken m 
hoofdstuk 9 
In de volgende paragtafen van deze promenade worden de hoofdstukken ν ял d/r 
proefschrift kort toegelicht Dit om de samenhang tussen de ondeidelen te tonen 
en de ontwikkeling ν,ιη ons onderzoek te schetsen 
Deel J: In vivo: Hoofdstukken 2,3,4. 
Het doel van de hier beschreven proeven was een antwoord te vinden op de 
volgende ι ragen 
I) Veroorzaakt foliumzuur, wanneer dat geïnjecteerd wordt in de 
neocortex, dezelfde clinische en electrofysiologlsche verschijnselen 
als (klassen van) convulsiva waarvan het werkingsmechanisme 
beter bekend Is? 
De verschijnselen die veroorzaakt woiden door foliumzuui werden vergeleken met 
de effecten veroorzaakt door kaïnezuur, carbachol neostigmine, bicucullme, 
penicilline, strychnine (hfdst 2) en baclofen (hfdst 3) In de neocortex bleek de 
door foliumzuur geïnduceerde epilepsie vergelijkbaar te zijn met de epilepsie 
veioorzaakt door GABAerge mhibitore stoffen met name Picrotoxine en bicucul-
lme Op basis van dit resultaat stelden we de hypothese op dat foliumzuur een 
CADA mhibitore werking zou kunnen hebben 
Het is bekend dat het deel van de prepinfomie cortex dat "area tempestas" wordt 
genoemd ("het gebied van de stormen") zeet ge\oelig is voor bicucullme Om onze 
hvpothese te testen in vivo hebben wij daarom ook m dit gebied het effect van 
de stoffen vergeleken Onze vraag was 
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2) Wordt het patroon van epileptogeniciteit zoals we dat zien In de 
neocortex ook waargenomen in de "area tempestas"? 
De verschijnselen veroorzaakt door het injecteren van foliumzuur bicuculhne en 
kaïnezuur m de prepinforme cortex woiden beschreven en vergeleken in hfdst 4 
Deel 2: In vitro: Hoofdstukken 5,6,7,8. 
Het uitgangspunt vooi de m vitro studies, beschreven in deel twee, was dat die 
stoffen, die geïnjecteerd m de neocortex de effecten van foliumzuur muteren, een 
OABAA inhiberend werkingsmechanisme hebben Ons doel was daarom de volgende 
vragen te beantwoorden 
3) Hebben folaten een zodanig effect op bet GABAA complex dat dit 
de epiieptogene verschijnselen kan verklaren? 
Onderzocht weiden de effecten van vier folaten op dne verschillende bindmgs-
plaatsen van het complex (namelijk de hoge affiniteit QABA plaats, de benzodia-
zepine plaats en de convulsieve plaats) De gevonden m vitro folaat effecten 
werden vergeleken met de epileptogeniciteit van de vier folaten m vivo (hfdst 6) 
Het bleek dat folaten de binding van het radioligand 3H-TB0B aan de convulsieve 
plaats op het complex verhogen 
Omdat het radioligand 3H-TBOB pas kort geleden geïntroduceerd is hebben wij m 
het voorafgaande hoofdstuk 5 de bmdingskaraktenstieken beschreven zoals WIJ 
die hebben gemeten 
De gevonden verhoging van de 3H-TBOB binding oiv de folaten leidde tot de 
volgende vragen 
4) Door welk mechanisme verbogen de Maten de 3H-TBOB binding? 
De invloed van foliumzuur op de bindmgskaraktenstieken van het convulsivum 
3H-TBOB wordt beschreven m hoofdstuk 7 
5) Met welke plaats op bet ОАВАл complex been foliumzuur een 
interactie? 
In hoofdstuk S wordt het m vitro effect van foliumzuur vergeleken met dat van 
bicuculhne en dat van ßCCE 
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PARTIAL MOTOR EPILEPSY INDUCED BY 
INTRA-NEOCORTICAL ADMINISTRATION OF FOLIC ACID 
IN FREELY MOVING RATS 
COMPARISON WITH OABA-ERGIC INHIBITORY COMPOUNDS 
AND DIRECT EXCITATORY COMPOUNDS 
M G Ρ Feenstra, С M van Rijn, M L F Schoofs, 
Τ J A M van der Velden, A J M M Beekman and O R Hommes 
SUMMARY. 
Folic acid can evoke epileptic phenomena when it penetrates into the brain The 
biochemical background of this action is unknown A direct action of folic acid on 
synaptic receptors, specific the inhibitory receptors, has been proposed earlier 
Following this suggestion the epileptic phenomena caused by folic acid are 
compared to those of disinhibitory drugs (i e bicucullme, strychnine, penicillin and 
Picrotoxin) and to those of excitatory substances (i e kainic acid, carbachol and 
neostigmme) The epileptic phenomena induced by folic acid resemble closely those 
induced by the disinhibitory compounds, but differ in many respects from those 
induced by the direct excitatory drugs These findings support the suggestion that 
folic acid might block the inhibitory system 
INTRODUCTION. 
Folic acid and several of its reduced derivatives have been shown to have an 
epileptogenic action on the mammalian brain [24, 34, 43] High doses of these 
compounds are needed to produce epileptic effects after peripheral administration 
(225mg - 625mg Na-folate/kg bodyweight) near the LDso (450 mg/kg), but these 
doses can be considerably reduced when there is direct access to brain tissue (75 
mg/kg)[25 33] The epileptogenic potential of fohc acid has been studied in our 
department and used to develop a test model for anticonvulsant drug action on 
partial motor epilepsy, comparable to the penicillin model [1] In this thesis we 
used a modification of the model to investigate the mechanism of folic acid 
induced epilepsy 
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A major impetus for recent studies on the mechanism of the folic acid actions 
was the suggestion that folic acid might have a similar mechanism as kaimc acid 
a glutamate analogue with excitatory and neurotoxic properties [2 11 27 30 35, 
40 41, 44] However, the neurotoxic properties of folic acid seem to be different 
from those of kainic acid folic acid appeared to reproduce the distant but not 
the local neurotoxic effects of kaimc acid [6, 16, 20, 26, 31, 36, 47, 48] More 
over, direct excitatory effects of the folates are weak [2, 14, 15, 17, 19] In 
addition, it has been suggested that a dismhibitory action might be the basis of 
the observed epileptic manifestations of fobc acid [15, 17, 22, 38] 
The endogenous presence of reduced folates in the brain, blood and peripheral 
organs, and the presence of all kinds of folates in food [7] is a highly interesting 
fact in view of the epileptogenic action In addition to its presence m food, high 
amounts of folic acid are present in vitamin preparations [13] and folates have 
been proposed in the prevention of neural tube defects [42] 
The observation that folic acid showed a potentiation of epileptogenic kindling 
[32] suggests that folic acid, when repeatedly ingested or endogenously liberated, 
might exert excitatory effects 
In this study we describe behavioral and electrographical effects of mtracortical 
injections of low doses of folic acid and defined qualitative and quantitative 
measurements of fohc acid effects and compared the action of folic acid to that 
of a number of other epileptogenic substances with better known mechanisms of 
action 
MATERIALS AND METHODS. 
Subjects. 
Male Wistar albino rats (CPB/TNO, Zeist, The Netherlands) were used, with a 
weight of 200 + 10 g at time of surgery for those for observational experiments, 
and 260 ± 10 g for those for electrocorticographical experiments The animals 
were individually housed and allowed access to food and water ad libitum A 12 h 
light, 12 h dark cycle was maintained, light on at 7 a m The experiments took 
place in the light phase 
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Surgeiy 
The animals were anaesthetized by pentobarbital (45 mg/kg ip) and atropine 
(lmg/kg se) A polyethylene cannula (outer diameter 0 8 mm, inner diameter 0 4 
mm) [9] was implanted through a dnll hole in the skull 1 4 mm to the nght of 
bregma, where the sensorimotor cortex of the left hindleg is situated The cannula 
was fixed by acrylic cement The tip of the cannula, cut to an edge of 45° to 
facilitate the penetration of the dural membranes was 2 mm beneath the upper 
surface of the skull histological examination revealed that the tip was m lamina 
IV or V of the cortex The cannula could be connected to a flexible injection 
system This permitted free movement dunng administration of the drugs 
For electrocorticographical recordings the animals received 4 epidural (and 2 nasal 
reference) electrodes on the skull as well positions related to the bregma 
antenor 0 0 mm, lateral 3 6 mm, postenor 6 0 mm, lateral 4 0 mm (references 
antenor 6 0 mm, lateral 1 5 mm) The electrodes, stainless steel screws 1 mm χ 2 
mm, were connected to a minisocket (MTA, Cannon ΙΤΓ) and embedded m acrvlic 
cement Free movement remamed possible dunng ECoG registration The animals 
were left to recover from surgery for 5 7 days 
Clinical observations. 
The drugs, dissolved in distilled water, were injected through the cannula m a 
volume of 0 5 - 2 0 μΐ, with a rate of 0 5 μΐ/min One test per day was conducted 
The animals were observed for 1 5 h following injection of the drug For each 5 
mm penod the maximum values of the intensity of the single myoclonic jerks and 
the spread of the jerks over the body (extension),(table 1, when doubt, half 
points could be adjudged), the number of the seizures and the duration of the 
phenomena were noted In addition, the total number of the jerks was counted in 
four penods of 5 minutes, with intervals of 10 minutes (10-15, 25-30, 40-45 and 
55-60 minutes) All registrations were done on animals that were used for the 
first time after surgery 
HectTOcorticographical registrations. 
The ECoGs were recorded on a Siemens Elema S-channel mmgograph The amplifi­
cation filter had an upper limit of 15 Hz and a time constant of 1 2 sec Each 
ECoG registration was started at least 0 5 h m advance of injection of the drug 
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in order to ha\e a sufficient duration of baseline registration Λ marker was 
connected to one of the channels to allow registration of the jerks bv an obser­
vator who could not see the recordings on the paper 
Folic acid concentration determinations. 
Brain folic acid concentrations after intracortical injections were determined with 
HPLC using a modification of the method of Lankema et al [29] \ι selected 
times after injection, a column of cortical tissue around the cannula tract was 
excised and divided into three parts upper (containing cortex laver I II) middle 
(laver III-V) and lower (laver VI and paît of the corpus callosum) The pieces of 
tissue were frozen on dry ice and stored at - 30 CC The tissue was homogenized 
in 1 ml distilled water and 0 1 ml 0 1 % ascorbic acid solution After 3 mm 1 ml 
of a 10 % solution of trichloracetic acid in 0 1 M HCl was added After centn-
fugation for 5 mm at 2000 g, 1 ml of the supernatant was injected on a l ì cm 
Nucleosil 5C18 column (Chrompack, Middelburg, The Netherlands) A Waters M 45 
solvent delivery system was used at a flow rate of 0 7 ml/min The analytical 
column was protected bv a pellicular reversed phase precolumn (Chrompack) The 
eluent was 0 015 M citrate/phosphate buffer (pH 4 95 bv addition of HCl) with 1 
mg/1 sodium azide and 13 % methanol A Schoeffel 770 spectrophotometnc detector 
was operated at 280 nm The retention tune of folic acid was about 9 mm Blank 
samples showed no peak at this retention time Recovenes of folic acid were 85-
95 % The detection limit was about 0 1 ug/g (0 2 nmol/g) in brain tissue 
Chemicals. 
All chemicals were obtained from Sigma 
RESULTS 1 : Clinical effects of the drags. 
Folic acid. 
Folic acid produced partial motor epileptic phenomena when injected mto the 
nght sensonmotor cortex at a dose of 2 nmol or more (fig 1,2) The first visible 
signs were jerks of the left hindlimb At the 5 nmol dose, epileptic phenomena 
were observed at 7 out of 8 rats (fig 1) or at 7 out of 7 rats (fig 3) The signs 
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began 5 mm after the start of the injection (median value, range 3-8 mm n-7) 
The mtensity of the jerks increased with time, from a barely visible muscular jerk 
to a full contraction of the limb and a complete lift of the foot (fig 1) Dunng 
this 'developmental' phase the frequency of the visible jerks increased as well 
and the jerks spread from the hindhmb only (extension class 1) to the left 
forellmb (class 2) and sometimes to the left vibnssae and ear (class 3) 
Apart from the myoclonic jerks some focal and generalized seizures were seen, 
lastmg approximately 10 seconds The focal seizures were charactenzed by a 
rhvthmic succession of jerks, with a frequency of 2-3 Hz and with a larger 
extension and greater mtensity than during the mtenctal penods At the general­
ized seizures a clonus of the whole body was observed No other behavioral 
abnormalities were observed consciousness was unimpaired and grooming behavior 
was normal (the generalized seizures excepted) 
The duration of the motor symptoms after this dose of 5 nmol was 3 5 - 4 0 mm 
The end phase generally set in with a rapid, sometimes abrupt, decline in inten­
sity and frequencv (fig 2) and a prolonged fading out with irregular jerks 
Higher doses (10 -20 nmol) produced an increase in all measured parameters Thus, 
the intensity, extension and duration increased and seizures were more common 
(fig 1-3) However the delay of 5 mm after the injection did not change Animals 
injected with 20 or 30 nmol sometimes had an increased susceptibility to seizures 
Than, seizures occurred m a rapid succession and could easily be induced by a 
sound or by touching the animal, stimuli that otherwise had no effect on the 
course of the events 
Bicuculline. 
Bicuculline-methylchlonde produced partial motor epilepsy which was m many 
respects similar to the syndrome mduced by fobc acid (fig 3) However, it was 
more potent m that 10 times lower doses were active At the lowest dose tested, 
0 1 nmol, in some animals visible jerks with irregular frequency, low intensity and 
of a short duration were observed This contrasts with the 10 times higher dose 
of folic acid (1 nmole) which did not produce any visible jerks m the 4 tested 
animals Like folic acid, bicuculline showed a dose dependent increase in all 
measured parameters (fig 3) The dose response curve was however less steep and 
the duration did not increase above a value of approximately 35 mm 
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Каіпіс acid. 
Kainic acid was injected in doses varying from 0 02 to 20 nmol •Mthough limb 
jerks were occasionally observed, reproducible motor signs as shown by folic acid 
and by bicuculhne were never seen The same animals tested later did show the 
familiar responses to folic acid though Kainic acid induced variable signs reflect­
ing the epilepsy which this compound elicits m other (limbic) brain regions such 
as the hippocampus and the amygdala sniffing, head jerking, jaw movements 
freezing and clonic seizures of both forelimbs were observed [47] 
The phenomena following penicillin Picrotoxin strychnine, carbachol and neostig­
mine were observed in combination with ECoG recordings onlv and will be descn-
bed there 
Table I Classification of the mvoclonic contractions 
(•xtensuon (= spread) 
('lass/visible motor eifert in: 
1 only left hindlimb 
? left hindlimb and forelimb 
3 both left limbs ~ face 
4 contralateral 
Intensity 
Class/motot effect resulting in: 
1 jerking without lifting the limb 
2 jerking with lifting the limb 
3 associated axial turning 
4 rolling on the back 
Fig J see next page 
Fig 2 
Representative time/intensity 
diagram for the 4 tested doses of 
¡ntracortical injected folic acid 
The maximum intensity of the jerks 
(see Matenah and Methods) was 
determined ¡n 5 mm periods Short 
vertical bars indicate seizures. 
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Fig. 1 
Observation of the epilepsy in rats 
after intracortical injection of 
different doses of folic acid. Rats 
were observed for 90 min. The 
groups consisted of 12 (20 nmol), 
17 (10 nmol) , 8 (5 nmol) and 16 (2 
nmol) animals. The upper panels 
show percentages, tlie lower panels 
show median values. Details of 
spread and intensity are given in 
Materials and Methods. 
Fig. 3 
Observation of the epilepsy in rats 
after intracortical injection of 
different doses of folic acid 
(circles) and bicuculline methyl-
chloride (triangles). This population 
was different from that in fig 1. 
For the duration, spread (- exten-
tion) and number of jerks the 
median values are given (n=7). The 
range of the jerks for folic acid is 
given in the lowest panels. 
Fig. 3 
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RESULTS 2 : Electrocoiticographical effects of the drugs. 
FoUc add. (fig. 4) 
After intracortical injection of 5 nmol folic acid (10 rats) singular spike-waves 
appeared on the leads directly adjacent to the injection site within 2 min (fig 4a). 
The spikes increased in amplitude until after 5-10 min a maximum was reached. 
From the moment the jerks of the hindlimb were visible, an excellent correlation 
could be established between the spikes and the independently observed jerks (fig 
4b). The jerk frequency was maximal (0.2-0.3 Hz) between 5 and 15 min. One hour 
after injection no more spike-waves or jerks could be observed. In 3 of the 10 
rats 7-11 seizures were observed (fig 4c) while in 4 of the rats only one or two 
seizures occurred. 
Baseline ECoO: 1 week after implantation of the cannula and the electrodes. 
Bipolar recordings: the position of the electrodes and of the cannula is shown. 
Both olfactory electrodes serve as reference for the amplifier. 
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Electrocorticographical recordings of a rat intracorticaily injected with 5 nmol 
folic add. 
a. One minute añer injection. First spikes, the jerks are not yet visible and 
appear one min later 
b. Eight mm after injection. Every spike coincidence with a clearly visible jerk 
of the left hindlimb (marked on the lowest line) 
c. Thirty tree nun after mjectton, example of a seizure. 
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Blcuculllne. (fig. 5) 
Injection of 0.5-2 nmol bicuculline methylchloride (7 rats) produced a similai 
pattern of electrocorticographic signs. Large spikes were immediately visible aftei 
injection and showed an excellent correlation with independently observed jerks 
(fig 5a,b). The frequency (0.5-0.6 Hz) was higher than that observed for folic 
acid. Seizures were observed as well. 
,ί L ί ,1 ,i 
Τ — Γ 1 г г 
jerks 
a ,' ¡i ¡И / ^1 / ^^-f-;1 ι' ι1 .'ι1 щщн 
Fig. 5 
Electrocorticographica] recordings of a rat intracorticaUy injected with 2 nmol 
bicuculline methylchlonde. 
a. One min after injection. Spikes correlate with independently observed jerks 
of the left hindhmb (marked on the lowest Ime). 
b. Eleven min after injection. A seizure is registered. 
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Penicillin, (flg. 6) 
Penicillin (10-1000 I.U., i.e. 17-170 rnnol) (2 rats) also produced a similar pattern 
of spike-waves and seizures. The start resembled that of folic acid in that small 
spikes rapidly increased in amplitude. The spike frequency was high from the start 
(0.4-0.5 Hz) and the spike-waves correlated well with observed limb jerks (fig 6a). 
Only the higher dose (170 nmol) induced seizures (fig 6b). 
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Fig. 6 
Electrocorticographical recordings of a rat intracortically injected with 170 nmol 
penicillin. 
a. Forty min after injection. Spikes correlate with independently observed jerks. 
The jerks spread to the right limbs. 
b. A seizure, sixty-nine minutes after injection. 
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Picrotoxin, (fig. 7) 
Application of 2 nmol Picrotoxin (n-4) produced singular spike-waves, similar to 
those described for folic acid and bicuculline and penicillin (fig 7a). About 3 min 
after the start of the injection spikes appeared which increased in amplitude until 
a maximum was reached at about 10 min. The spikes were accompanied by myoclo-
nic jerks of the left hindleg. Seizures were observed as well (fig 7b). The dura-
tion of phenomena at this 2 nmol dose was about one hour. 
é^vr*™»-^^. ι I < ' 
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Fig. 7 
Electrocortícographical recordings of a rat intracortically injected with 2 nmol 
Picrotoxin. 
a. Four min alter injection. Spikes appear on the ECG. 
b. Spikes (correlating with jerks) and a seizure. 
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Strychnine, (fig 8) 
Within 2 4 mm after injection of 100 nmol strychnine (3 rats) spike waves were 
observed, which almost immediately reached maximal amplitudes (fig 8a) Limb 
jerks correlating with spikes were observed, but the relation was less strong 
than obtained with the pnor named compounds (fig 8b) The dose did not induce 
seizures 
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Electmcorticographical recordings of a rat mtracortically injected with 100 nmol 
strychnine. 
a Two mm after injection spikes are appearing, weak left hmdlunb jerks were 
observed 
b Twenty one mm after mjection Spikes, not correlatmg with jerks 
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Kalnic arad, (fig 9) 
A totally different pattern of electrocorticographic and behavioral signs was 
produced by kainic acid (fig 9a) Kamic acid was tested in doses of 1 nmol (4 
rats) and 0 3-5 nmol (3 rats) For all doses electrographic signs were first seen 
between 4 and 30 mm after injection Very high trequency spikes with rapidly 
increasing amplitude appeared and stopped abruptly The spikes complexes disap-
peared and reappeared m steady progression For the low doses (0 3 and 1 nmol) 
these events were often not related to any visible motor effects (fig 9b) Limb 
jerks and seizures related to spike complexes were observed only for the high 
dose (5nmol), but not always during some of these spike complexes the rats 
were lying quietly while at other times only the general activity (walking 
sniffing) was increased In contrast to the results described above for the first 
four compounds where jerks invariably started from the contralateral hindhmb, the 
jerks induced by kamic acid were sometimes in the ipsilateral front- or hindleg 
With time the spike complexes were preceded by repeated single spikes, these 
spikes were however never accompanied by kmbjerks (fig 9c) The duration of the 
events was dose dependent 0 3 nmol produced effects for 30 nun, 1 nmol for 30-
90 mm, the 5 nmol dose for more than 120 mm 
?B 
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Electrocorticographical recordings of rats intracortically injected with 
kainlc acid. 
a. Thirty-four min after 0.3 nmol. Single spikes and a spike complex without 
any behavioral or motor effects 
b. Four nun after 1 nmol. A spike complex, no clear behavioral changes were 
observed. 
c. Fifty-seven min after I nmol. Repetitive single spikes without any sign of 
behavioral or motor changes are followed by a spike complex. 
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Caibachol. (fig. 10) 
Low doses (1-2 nmol) produced complexes of high frequency spikes (fig 10a)(4 
rats). No jerks were observed. The total duration of the events was about 20 min. 
Higher doses (5-20 nmol) produced long lasting complexes of high frequency 
spikes, with different patterns of amplitudes (fig 10b). These doses resulted in 
generalized tremors. Occasionally observed jerks never could be related to indivi­
dual spikes. 
a • '•• -~».v^^ ^^v*« •—· " * .інъчРіч^гфіц^іщіт^нушщньрі 
Fig. 10 
ElectrocorticographicaJ recordings of rats intracorticaUy injected with 
carbacbol. 
a. Four mm after injection of 2 nmol. Very high frequency spikes without 
observable abnormalities. 
b. Twelve min after 5 nmol. Constant spike formation coincides with the 
development of generalized tremors. 
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Neostigmine, (fig. 11) 
Neostigmine, injected in a dose of 100 nmol (2 rats), produced similar effects as 
did carbachol, but with a different time course. Ten to twenty min after injection 
spike complexes appeared (fig Ha). On observation the animals showed tremors 
but no jerks. The complexes appeared throughout the registration period (90 min). 
In the later stages generalized jerks were sometimes observed but a relation 
between the spike complexes and the motor events was not found (fig 1 lb). 
Fig. 11 
Electrocorticographical recordings of a rat intracortically injected with 100 nmol 
neostigmine. 
a. Thirty min after injection, spike complex without any related motor effects. 
b. Eighty-nine min. some generalized jerks were observed, but not related to 
individual parts of the complex. 
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RESULTS 3 . Cortical concentrations of folic acid. 
Small blocks of cortical tissue including the cannula tract did not contain folic 
acid in nomnjected or saline injected rats The cortical tissue blocks weighted 20-
35 mg and contained 15-30 % of the injected amount, determined between 2 and 
20 minutes after injection 
A time curve was produced by determining the concentration of folic acid after 
injection of 5 nmol The results are presented in table 2 While the upper laver 
showed initially high but in time decreasing levels the the amounts in the middle 
layer increased in time Assuming that 1 g of tissue is equivalent to 1ml the 
concentration in the upper and middle layers vaned from 10 to 90 uM, and was 35 
uM after 20 mm in the middle layer where the tip of the cannula was situated 
Table 2 Time dependent concentiations of folic acid around the cannula after 
injection of 5 nmol m the cortex 
time 
Layer 
upper 
middle (nmol/g) 
lower 
found (nmol) 
jerk intensity 
2 mm 
87.8 ± 17.5 
14.7 ± 6.1 
3.2 ± 0.5 
1.0 ± 0.1 
nd 
10 mm 
81.9 ± 16.3 
29.0 ± 3.1 
14.5 ± 7.7 
1.5 ± 0.2 
1 
20 min 
51.9 ± 4.8 
34.5 ± 8.4 
16.1 ± 5.9 
.65 ± .12 
1.5 
Rats were injected with 5 nmol folic acid, of which 0 65 - 15 nmoles was found 
back Concenti ations are means ± SEM, л - ί The top intensity m the 5 mm 
penod before decapitation is given as the median value of the 5 animals At the 2 
mm penod no reliable sconng of the intensity was possible 
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DISCUSSION. 
The model 
Fohc acid injected into the neocortex produces a clinical syndrome, charactenzed 
by myoclonic jerks The jerks are easy to quantify and appear to be dose depen­
dent We have used intraneocortical application of folic acid as an in vivo model 
to study partial epilepsy This model has some advantages compared to the model 
described by Arends (who used heat lesions to destroy the blood brain barner 
after which he applied the drugs penferal [1]) because a) the technique is very 
simple, b) the animals can be injected many tunes, c) from this it follows that 
the animals can be their own controls and d) the effective dosage of the convul­
sive or anticonvulsive drugs of study can be defined very reliably 
Comparison of the epileptogenic actions. 
In order to study the mechanism of the epileptogenic action of folic acid we 
compared in our model the action of fohc acid to that of convulsants with a 
better known mechanism Clinical and electrographic features have been studied 
All tested compounds induced epileptic activity when injected directly into the 
neocortex, in conformity with earlier reports in which the compounds were tested 
in other bram regions, or by other techmques [4, 6, 10, 12, 21, 37, 39, 45, 46] 
Roughly, two groups of convulsive patterns could be distinguished 
- The clinical signs of group 1 consisted essentially of myoclonic unilateral 
jerks of the hmdlimb The electrographic signs showed singular spike-waves, 
which were synchronized with limbjerks The clinical and electrographical signs 
were easy to quantify Group 1 convulsions are mduced by folic acid, bicucullme, 
Picrotoxin, penicillin and strychnine 
- The clinical effects of group 2 were essentially characterued by a limbic 
character Polyspike activity was observed, frequently not synchronized with clini­
cal signs The clinical signs are vanable and not easy to quantify Group 2 
convulsions are induced by kamlc acid, carbachol and neostigmine 
Characteristics of the two dnig-groups. 
- A common biochemical feature of the drugs inducing group 1 effects is that 
these compounds are thought to interfere with GABA mediated inhibition. Bicucul­
lme is a well known GABA antagonist at the GABAA receptor complex [18] 
Picrotoxin is thought to block directly the permeability of the GABA-gated Ch 
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channel [18] Partial GABA antagonism is the supposed mechanism of penicillin [3], 
though the exact point of interaction is not known (28] Strychnine is a glycine 
antagonist However strychnine binds with the GABAA sites as well (8) Moreover 
a coexistence of GABA and glycine receptors has been suggested [49] The epilep­
tic action of strychnine may results from an blockage of GABA- or glycine media­
ted inhibition In conclusion, all compounds in group 1 seem to be disinhibitory 
substances 
- The substances in group 2 seem to have direct excitatorv potencies themsel­
ves Kainic acid is a glutamate agomst [30] Glutamate is an excitatory neurotran­
smitter Carbachol is an acetylcholine agonist Acetylcholine may have direct ex­
citatory properties m certain brain areas [46] Neostigmine is an acetylcholinester­
ase inhibitor, thus potentiates the action of acetylcholine [37] 
Mechanism of folic add action. 
These m vivo findings suggest that folic acid blocks the inhibitory svstem rather 
than that it potentiates the excitatory system This result strengthens the in vitro 
electrophysiological results published before a blockade of the GABA response was 
found to be induced by fobc acid [38] The molecular mechanism of this action 
remains to be elucidated 
Following mtracortical injection of 5 nmoles of folic acid, the concentration in 
the brain near the cannula is 10 μΜ - 90 μΜ, after injection of 30 nmol, 80 ug/g 
- 180 μΜ was found This data are in agreement with earlier results from our 
laboratory the folic acid concentration after intravenous injection (after a heat 
lesion of the blood brain bamer) has a value of 150 μΜ m the focus [23] 
CONCLUSION. 
- The epileptic phenomena induced by folic acid resemble closely those induced 
by disinhibitory compounds, but differ in many respects from those induced by 
direct excitatory drugs 
- The effective folate concentrations are of imcromolar order 
These observations were the basis of our further biochemical studies on the 
influence of folates on the GABA* receptor complex We refer to chapters 6 and 
7 for our reports on this investigations 
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R(-)-BACLOFEN: FOCAL EPILEPSY AFTER 
INTRACORTICAL ADMINISTRATION IN THE RAT 
Γ M \an Rijn M J van Berlo M O P Feenstra 
M L F Schoofs en О R Hommes 
SUMMARY 
R( ) or S(+(baclofen •were injected into lamina IV-\ of the sensonmotor cortex 
of the rat Clinical observation and ECod registration revealed that partial 
epilepsv with focal motor symptoms developed following injection of R( )-baclofen 
with an EDso of 0 25 nmoles a mean latenc\ of 17 mm independent of the dose 
and a duration of more than 5 h at a dose of 5 nmoles S^l-Baclofen was inef­
fective at doses of up to 5 nmoles (2 \ bDioo (-) baclofen) indicating a stereo­
selective action of the (-(-isomer 
INTRODUCTION. 
There is at present considerable interest in the role of gamma-aminobutvnc acid 
(GABA) in seizure disorders2 3 2 6 Impaired GABA-mediated inhibition is probabh 
one ot the cellular abnormalities leading to focal epilepsv10 It has been suggested 
that an important cause of seizures mav be the loss of inhibitory GAB^ergic 
nerve terminals at sites of focal cortical epilepsv18 We are studvmg focal epilep­
sv bv intracortical application of epileptogenic and antiepileptic substances 
including GAB Л agonists and antagonists As part of this investigation we studied 
in our in vivo model the effect of the GAB Л denvative baclofen ß-p-chlorophe-
nvl-K-aminobutvnc acid 
Pharmacology. 
GABA is an important inhibitory neurotransmitter10 The receptors for this 
neurotransmitter can be classified as 
- The classical GABAA receptors located on the postsynaptic membrane, are 
linked to chloride channels such that receptor activation bv GABA leads mostly to 
3S 
an inward movement ol CI- resulting in a hvperpolansation ι e in an inhibition 
of the postsynaptic cell6 Bicucullme antagonizes this action of OABA whereas 
muscimol mimics it Baclofen has no effect on these GABAA receptors4 
- In 19S0 Bowerv et al s desenbed ГтЛВАв leceptors Bv definition these 
GAB AB receptors are activated b\ ( ) baclofen and GAB A and are not blocked bv 
bicucullme Muscimol weakly activates these receptors6 The overall distribution 
of GABAB sites differs from that of the GABAA sites In the cerebral cortex e g 
there is a high density of GAB \A sites and a lower concentration of G AB AB 
sites10 
Activation of GABAB receptors located on presynaptic excitatorv terminals is 
thought to lead to a reduction of evoked excitatory neurotransmitter release 
resulting in a decreased excitation of the postsynaptic cell25 2 7 2 9 This effect is 
probablv due to a blocked inward flux of Ca2 t and a decreased Ca2*-dependent 
vesicular release process6 Indeed manv studies have shown an inhibitory action 
on the firing of neurones m in vivo animal studies7 9 M 2 2 Baclofen is used 
clinically to alleviate spastic disorders (review4) 
In addition to these presynaptic GABAB receptor effects a postsynaptic action 
has recently been reported24 It is suggested that baclofen has a post-svnaptic 
effect bv increasing membrane potassium conductance resulting m hvperpolansa­
tion Activation of GABAB sites located on inhibitory intemeurones would then 
result in disinhibition24 In addition to the inhibitory action of baclofen some 
authors report excitatory or disinhibitorv actions in in vivo expenments 1 1 1 6 2 0 2 1 
In m \itro expenments inhibitory12 " 2 e and disinhibitorv15 or excitatory24 
actions of baclofen were found 
As the mechanisms of action of baclofen are not vet clear, predictions of in vivo 
effects of topical administration of baclofen are difficult to make M e report focal 
epilepsy induced bv intracortical administration of R(-)-baclofen in the rat 
MATERIALS AND METHODS 
Subjects. 
The subjects were male Wistar albino rats with a weight of 200 + 10 g at time of 
surgery for those receiving a cannula only, and 260 ± 10 g for those receiving 
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electrodes as well The animals were individually housed and allowed access to 
food and water ad libitum A 12 h light. 12 h dark cycle was maintained, light on 
at 7 a m The experiments took place in the light phase 
Surgery. 
Details of the methods of application will be published elsewhere (Feenstra et al, 
in prep ) In short 
The animals were anaesthetized by pentobarbital A polyethylene cannula (outer 
diameter 0 8 mm, inner diameter 0 4 mm) was implanted through a dnll hole in 
the skull 1 4 mm to the right of bregma, where the sensonmotor cortex of the 
left hind leg is situated12 The cannula was fixed bv acrvlic cement The tip of 
the cannula was 2 mm beneath the upper surface of the skull histological ex­
amination revealed that the tip was in lamina IV or V of the cortex Cortex 
laminae were determined according to Kneg13 The cannula could be connected to 
a flexible injection system This permitted free movement dunng administration of 
the drugs 
Some animals received 4 epidural (and 2 nasal reference) electrodes on the skull 
as well, positions related to the bregma anterior 0 0 mm, lateral 3 6 mm, posterior 
6 0 mm, lateral 4 0 mm (references anterior 6 0 mm, lateral 1 5 mm) The electro­
des, stainless steel screws 1 mm χ 2 mm, were connected to a mmisocket (MTA, 
Canon ITT) and embedded in acrylic cement Free movement remained possible 
dunng ECoO registration The animals were left to recover from surgery for 5-7 
days 
The experiments. 
The drugs, dissolved in water, were administered into the cortex through the 
cannula in a volume of 0 5 ці For doses exceeding 10 nmoles a larger volume was 
injected, maximally 2 μΐ The injections were performed with a velocity of 0 5 
lil/min Each dose was tested on all the animals m the group, only 1 dose/day 
The ECoGs were recorded on a Siemens Elema 8-channel mingograph The amplifi­
cation filter had an upper limit of 15 Hz and a time constant of 1 2 sec 
We tested (-)-baclofen and (+)-baclofen as follows. 
Animals with a cannula only 14 animals received (-)-baclofen in a dose varying 
from 0 05 to 10 nmoles, 4 animals received (+)-baclofen in a dose varying from 
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0 05 to 10 nmoles, 9 animals received (+)-baclofen in a dose varying from 10 to 40 
nmoles In the past we studied the effect of NaCl solution extensively 
Animals carrying electrodes as well were treated as follows 
1 animal received (-)-baclofen in a dose varying from 0 05 to 10 nmoles, 1 animal 
received (+)-baclofen m a dose from 0 05 to 10 nmoles, 1 animal received (+)-
baclofen in a dose up to 80 nmoles m 2 ці, 1 animal received a daily dose of 0 05 
nmoles (-)-baclofen, for 15 days, 1 animal received NaCl in the same concentra­
tions as baclofen 
The animals were observed for 1 5 h following injection If an ammal showed 
abnormal behaviour the delay time was noted and the abnormalities were descri­
bed, no quantifications were made 
Each ECoG registration was started at least 0 5 h m advance of injection of the 
drug to have a sufficient duration of baseline registration The events m the 
animals carrying electrodes were marked on the registration paper For the dose 
of 5 nmoles (-)-baclofen the registration and observation were extended to 8 h 
Drags. 
R(-)- and S(+)-baclofen HCl were kindly donated by Ciba-Geigy BV, Amhem, The 
Netherlands 
RESULTS. 
Following injection of (-)-baclofen into the right sensonmotor cortex of the rat, 
hmd leg area, lamina IV-V, clinical as well as ECoG abnormalities developed 
The clinical events were characterized by intermittent myoclonic jerks of the hmd 
leg The jerks were clearly observable saccadic flexion movements of the leg, of a 
constant pattern They resembled focal epileptic phenomena mduced in this model 
by fohc acid, penicillin or bicuculhne The myoclonus did not spread to other 
parts of the body, nor did generahzed seizures develop Apart from one animal, 
who grew aggressive once only, no other behavioural abnormalities were observed 
consciousness was unimpaired, grooming behaviour was normal We never saw 
abnormalities following injection of NaCl 
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The clinical s\mptonis were accompanied bv spike-wave complexes and solitary 
spikes on the ECoG (Fig I1-9) The complexes, which had a duration of about 1 
sec consisted of spike-waves in a frequency of 6/sec (Fig Ы There were 10 
complexes in 1 mm at the most The voltage of the spikes was about 500 ц (Fig 
h A) The spike-wave complexes as well as the spikes correlated with visible 
jerks, but some jerks had no correlates on the ECoG (Fig H) On the control 
ECoGs registered after injection of NaCl isomolar to the tested dose of baclofen 
no discharges were seen (Fig U) 
Of the clinically observed animals 50% (7/14) showed this response at a dose of 
0 25 nmoles (-)-baclofen All the animals responded to 2 5 nmoles (-)-baclofen 
(ED100) (Fig 2) No discharges were seen on the ECoG after 15 times a daily 
dose of 0 05 nmoles (-)-baclofen (Fig h) (i-)-Baclofen had no influence on the 
behaviour and the ECoG up to a dose of 5 nmoles (2 χ EDioo for (-)-baclofen) In 
the observation group 4 out of 9 animals showed very weak jerks following 40 
nmoles (+)-baclofen (dissolved in 2 μΐ) The animal carrying electrodes responded 
only to SO nmoles (+)-baclofen, on the ECoG spike-wave complexes not resemblmg 
those described above were seen 
(Fig Is) The weak jerks cor­
responded with these ECoG abnor­
malities 
The jerks following (-)-baclofen as 
well as those following (-)-baclofen 
started with a median delay of 16 
mm. range 3-36 mm (mean 17 + 7 
mm) No correlation between the 
dose and the delay time could be 
seen 
The duration of the clinical signs 
was 5 h in the animal we observed 
and registered for 8 h following 5 
nmoles (-)-baclofen Spindle-like 
abnormalities on the ECoG were 
still present after 8 h, but had 
disappeared after 24 h (Fig b e s ) 
% of animals v. ith jerks -
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(Fig i see next page) 
Dose-response curve 
Intracorticaliy injected dose of 
(-)-baclofen (n - 14) ( -a- ) and of 
(+)-baclofen (n = 9) ( -·- ) needed 
to produce visible jerks of the hind 
leg The jerks were clearlv visible, 
observed during at least 10 mm 
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Fig. 7 
ECoGs: bipolar recordings; the position of the electrodes and the cannula is 
shown. Both olfactory electrodes serve as reference for the amplifier. 
1, baseline: I week after implantation of the cannula and the electrodes; 
2, 40 min after admimstration of 0.05 nmole (-)-baclofen on the 8th day: no 
abnormalities; 
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3, 40 min after administration of 2 5 nmoles (-)-bacJofen spike-wave complexes 
with a duration of about 1 sec, 
4, as 3, fast paper speed a complex consistmg of spike-waves with a frequency 
of 6/sec, 
5, 40 mm after administration of 80 nmoles (+)-baclofen spike-wave complexes 
not resembhng those m 3, 
6, 40 mm after admmistration of 5 nmoles (-)-baclofen spike-waves and spikes 
correlating with visible jerks, some jerks have no reflection on the ECoO, 
7, 2 5 h after 5 nmoles (-)-baclofen spike wave complexes are still present, 
jerks were seen, 
8, 7 5 h after 5 nmoles (-)-baclofen spmdle-hke abnormalities, no visible jerks 
anymore, 
9, 24 h after 5 nmoles (-)-baclofen no abnormalities on the ECoO 
DISCUSSION. 
Our results show that mtracortical administration of baclofen in the rat causes 
partial epilepsy with focal motor symptoms The action shows stereoselectivity for 
the (-)-isomer 
The EDioo is 2 5 nmoles This dose is comparable to that of bicuculline-metho-
chlonde or folic acid usmg the same model (Chapter 2) Also the appearance of 
the jerks, viz, flexion movements of the hind leg, is comparable to that observed 
following the administration of bicuculline or folic acid However some important 
differences were noted between baclofen, bicuculline and folic acid the saccadic 
feature of the flexion is specific for baclofen The jerks following bicuculline or 
folic acid occur singly (Chapter 2) The clinical signs mduced by baclofen are 
limited to movements of the hind leg, we never observed any spreading to other 
parts of the body, nor were generalized seizures seen, not even after injecting 10 
nmoles (-)-baclofen Generahzed seizures do occur following bicuculline or folic 
acid In addition the time-course of the effect shows a different pattern the 
onset of the effect of bicuculline and folic acid is rapid, always within a few 
mmutes, and the duration of the effect at the doses mentioned here is less than 
1 5 h In contrast, we observed a considerable delay of 17 mm and a duration of 
several hours m the effect of (-)-baclofen Tested m our model up to 100 nmoles, 
muscimol, a potent OABAA and weak GABAB activator, does not induce epileptic 
phenomena 
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Some earüer reports on the possible epileptogenic action of baclofen have been 
pubhshed in the baboon epileptic responses to photic stimulation could be aboli-
shed bv 2 mg/kg iv (-) baclofen (Ю - 3 moles), "but a toxic syndrome charac­
terized by unpaired alertness, ataxia, loss of muscle tone, rhythmic limb jerks and 
abnormal slowing of the background EEG rhythms with irregular or rhythmic 
spikes and spikes and waves" occurred following 4-8 mg/kg i v 2 0 In mice 100 
mg/kg ι ρ baclofen causes generalized convulsions17, as it does in rats after 50-
100 mg/kg ρ о l l 
In contrast to the epileptogenic action, some authors do find antiepileptogemc 
properties of baclofen baclofen affords protection against convulsions induced by 
electroshocks, hyperbaric oxygen, 3-mercaptopropionic acid and audiogenic stimuli 
in mice, but not against convulsions induced by pentetrazole strychnine, or 
Picrotoxine (ref 3 10 mg/kg ι ρ , ref 8 15 mg/kg ι ρ , ref 17 3 mg/kg ρ о ) 
The results of Meldrum20 suggest a biphasic action of (-)-baclofen, being in­
hibitory in low and epileptogenic m high doses We intend to test the antiepilep-
tic action of low dose baclofen in our model 
The mechanism of action of baclofen is still unclear Peet and McLennan24 
proposed that activation of postsynaptic GABAB receptors, located on inhibitory 
feed-forward neurones, reduces the inhibitory postsynaptic potentials, resulting in 
a disinhibition Although in our hands the effects of (-)-baclofen show a superfi­
cial resemblance to the effects of a disinhibitory substance like bicucullme, the 
different appearance of both clinical and ECoG signs makes it unlikely that the 
proposed disinhibition by (-)-baclofen resembles the disinhibition caused by 
bicucullme 
CONCLUSION. 
Intracortical application of the GABA derivative R(-)-baclofen produces focal 
motor epilepsy in rats This action is stereoselective for the (-)-isomer 
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A LOW DOSE OF FOLIC ACID IN 
THE PREPIRIFORM CORTEX OF THE RAT 
DOES NOT INDUCE EPILEPSY 
With the participation of R H J Ans, 
J F Rodngues de Miranda and O R Hommes 
SUMMARY. 
The amount of folic acid (5 nmoles) needed to mduce m all the tested animals 
epileptic phenomena in the neocortex appears to be ineffective in the prepinform 
cortex In contrast bicucullme is more effective in the prepinform cortex than in 
the neocortex These observations elicit some questions with respect to the 
mechanism of action of both folic acid and bicucullme 
INTRODUCTION. 
Recently, Piredda et al [8] located a small site in the prepinform cortex of the 
rat from which bilateral motor seizures can be elicited by a single unilateral 
injection of extremely low doses of convulsant compounds, such as kaimc acid, 
bicucullme and carbachol [1, 6, 7] They named this site the 'area tempestas' [2] 
Viewed m the light of our previous studies mto the epüeptogenicity of folic acid 
m the neocortex [chapter 2], we considered the possibility that this compound can 
elicit seizures from the area tempestas as well We evaluated by means of clinical 
and electrocorticographical observations the effects of injection of folic acid, 
bicucullme and kaimc acid mto the area tempestas 
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MATERIALS AND METHODS. 
Subjects and Surgery. 
Details of the methods of application are described elsewhere (chapter 2) Some 
modifications Anaesthetized male Wistar Albino rats (250 - 300 g) were placed m 
a stereotactic apparatus with the incisor bar at the level of the mteraural line A 
22 gauge (diameter is 1 6 mm) stainless steel guide cannula was implanted through 
a drill hole in the skull position related to the bregma 2 4 mm anterior, 3 0 mm 
to the right The tip of the cannula was 6 5 mm beneath the upper surface of the 
skull histological examination revealed that the tip was in the prepmform cortex 
The stainless steel cannula could be connected to a flexible injection system to 
permit free movement during administration of the drugs The animals received 
electrodes on the skull as described in chapter 2 and were left to recover from 
surgery for 5-7 days 
Administration of the drugs. 
The drugs dissolved in water, were administered into the prepmform cortex m a 
volume of 0 5 ul in two minutes We tested the drugs as follows Before injecting 
the test drugs, 0 5 μΐ of a physiological salt solution was mjected and the ECoü 
registered for thirty minutes to have a baseline registration Six animals were 
mjected with 5 nmol folic acid Twenty four hours later 4 of the animals received 
0 25 nmol kamic acid and 2 of the animais received 0 10 nmol bicuculline methvl-
chlonde On the third day the animals were reinjected with 5 nmol folic acid The 
animals were observed and the ECoG was registered for 90 minutes 
RESULTS. 
Effects of the drugs. 
- Folic acid mjected on the first day did not induce any behavioral or electro-
graphical abnormalities Remjection of folic acid on the third day did not induce 
abnormalities either, while injection with kainic acid on the second day and 
remjection on the fourth day did mduce limbic seizures 
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- Kainic add: Within 4 - 3 0 minutes from the beginning of the administration 
of kainic acid, epileptic seizures were observed The start of the seizures was 
charactenzed bv myoclonic jerks of the forelimb contralateral to the mjected sue 
progressing to clonic contraction of both forelimbs Subsequently recurrent clinical 
signs of limbic seizures were observed [5, 10]. these included wet dog shakes 
stereotyped motor activities such as turning round and round anticlockwise, 
headbobbing, chewing with salivation falling, rearing and headweaving The 
electrocorticographical signs consisted of mainly ipsilateral. spiking activity with 
vanable frequency (fig 1c) The spike complexes disappeared and reappeared 
numerous times 
- Bicuculline: A totally different pattern of electrocorticographic and behavio-
ral signs was produced by bicuculline We observed only mvoclonic jerks of the 
left forelimb accompamed bv a turning of the head to the nght within 2 mm 
after the start of the injection No limbic signs were observed The ECoG signs 
consisted of singular spike wave discharges, correlating with the myoclonic jerks 
The ipsilateral leads showed the highest amplitudes (fig lb) 
Comparison- Prepiiiform-cortex versus Neo-cortex. 
In the neocortex 5 nmol of folic acid induced m all the tested animals epileptic 
phenomena This dose did not mduce any epileptic signs when mjected m the 
prepinform cortex This is m contrast to the observations of the effective doses 
of bicuculline and of kainic acid m the two areas Moreover, the epileptic pheno-
mena induced by the indicated doses of the latter two compounds in the prepin-
form cortex, were far more severe than those elicited by these low doses in the 
neocortex (see chapter 2 and table 1) 
Table 1 Epileptogenic effect of convulsants injected in the prepmfonn cortex und 
the neocortex (Data for the neocortex are from chapter 2) 
Site 
Compound 
Folic acid 
Kainic acid 
Bicuculline 
Prepinform Cortex 
dose incidence 
(nmol) (effect/total) 
5 0/6 
0.25 4/4 
0.1 2/2 
Neocortex 
dose incidence 
(nmol) (effect/total) 
5 10/10 
0.3 3/3 
0.5 7/7 
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Above results are in agreement with those described bv Gale and Piredda [2, 6] 
However some differences with their reports are observed 
The electrocorticographical changes in our experiments were mainlv recorded 
from the ipsilateral conex near the focus, whereas generalized seizures are 
described bv these named authors 
- We found clinical differences between the seizures elicited by bicucullme 
(mvoclomc jerks) and those elicited by kaimc acid (full limbic seizures), as well 
as electrographical differences, Gale and Piredda found no clinical, nor ECoG 
differences between the substances 
Possibly we did not inject the compounds into precisely the 'area tempestas' 
which is only a small part of the prepinform cortex the area is verv small and 
can be easily missed [6) Histological examination revealed that we did inject mto 
prepinform cortex 
We conclude therefore that the prepinform cortex has a low susceptibility for 
folic acid with respect to induce epileptic phenomena, but a high susceptibility for 
bicucullme In the neocortex, the epileptogenic potency of folic acid is only 
shghtlv less than that of bicucullme 
DISCUSSION. 
In this thesis we hypothesize a relationship between the effects of folic acid and 
those of bicucullme We propose that a GABAergic inhibitory action may be the 
biochemical basis of the epileptic phenomena by folic acid However the observed 
differences between the effects of folic acid and bicucullme as reported in this 
chapter do evoke some questions 
1) Do the observed phenomena induced by either folic acid or bicucullme indeed 
follow from an interaction of the drugs with the GABAA complex'' 
2) If so, do the substances compete for the same binding sites on the complex7 
Ad 1) It is reported that besides GAB A other bicucullme sensitive neuronal in-
hibitors are found m the central nervous system [3] So the phenomena induced 
by bicucullme m the prepinform cortex need not result from a GABAA receptor 
antagonism 
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On the other hand: there may be regional differences in the sensitivity of recep­
tors to ligands [9]. Recently it was suggested that there are regional differences 
in the gene expression of subunits of the GABAA receptor complex [4]. So, our 
hypothesis (chapter 2) that folic acid interacts with the GABAA complex need not 
to be in conflict with the possibility that the phenomena induced by bicuculline 
do result from an interaction with the same complex as regional differences for 
the interaction with folic acid may exist. 
Ad 2) In the second part of this thesis experiments concerning this question will 
be described, Therefore we will return to this point m the conclusion. 
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Fig. I 
a Baseline ECoO. Bipolar recordings, the position of the electrodes is shown. 
b Recordings of a rat injected with 0.25 nmoi kainic add into the prepiriform 
cortex. A spike-wave complex not resembling the single spikes-waves ob­
served in fig 1c is seen. 
с Recordings of a rat injected with 0.1 nmol bicuculline-methylchloride into 
the prepiriform cortex. Focal single spike-waves are registered. 
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PROMEHADE 2 ENGLISH 
In the first part of this thesis we described the m vivo investigations of the 
epileptogenic mechanism of folic acid 
- Injected into the neocortex folic acid induces epileptic phenomena resem-
bling tho'se induced by OABAergic inhibitory compounds, especially bicuculhne 
and Picrotoxin (When injected into the prepmform cortex however, fohc 
acid does not mimic the action of bicuculhne In the conclusion we will 
return to this last observation) 
- Major differences are found between the phenomena caused by folic acid and 
those caused by direct excitaton' drugs such as kaimc acid 
- The phenomena induced bv the GABAB agonist baclofen differ from those bv 
folic acid 
From these results, supported by data published before (cf Introduction), we 
hypothesized that folic acid exerts its epileptogenic action through an interaction 
with the GABAA receptor complex 
In the second part of the thesis we descnbe the m vitro tests concerning our 
hypothesis 
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In het eerste deel van dit proefschrift werden de m vivo studies beschreven naar 
het biochemisch mechanisme dat aan de epileptogene werking van foliumzuur ten 
grondslag ligt 
Na injectie m de neocortex veroorzaakt foliumzuur epileptogene verschijn-
selen die sterk lijken op verschijnselen geïnduceerd door GABA-inJiiberende 
stoffen zoals bicuculhne en Picrotoxine (Echter geïnjecteerd m de prepin-
forme cortex imiteert foliumzuur het effect van bicuculhne met Op deze 
waarneming zal m de conclusie nader worden ingegaan ) 
- Er worden grote verschillen gezien tussen die verschijnselen die door folium-
zuur veioorzaakt worden en die welke het gevolg zijn van direct exciterende 
stoffen zoals kamezuur 
- De verschijnselen geïnduceerd door de GABAB agonist baclofen verschillen 
van die veroorzaakt door foliumzuur 
Naar aanleidwg van deze resultaten, gesteund door eerder m de hteratuur ver-
schenen gegevens (zie 'Introduction'), stelden we de hypothese op dat foliumzuur 
epileptogeen werkt dooidat het een invloed heeft op het OABAA receptor complex 
In het tweede deel van dit proefschnft worden de m vitro experimenten beschre-
ven die we uitvoerden om deze hypothese te testen 
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THE BINDING OF THE CAGE CONVULSANT [3HJTBOB 
TO SITES LINKED TO THE GABAA RECEPTOR COMPLEX 
С M van Rijn, J F Rodngues de Miranda 
Τ J A M van der V elden O R Hommes 
SUMMARY. 
[3H]1 BOB binds to specific sites on crude synaptic rat bram membranes The 
dissociation constant Kd determined from saturation experiments is near « nM and 
the receptor density RT IS about 20 pmoles/g wet tissue Non-specific binding 
constitutes about 35 % of total binding at 4 nM (3HJTBOB 
Association of l3H]TBOB is monophasic, but its dissociation is biphasic From the 
kinetic data Kd values of 8 nM (70 % of the binding sites) and 20 nM (30 % of 
the bindmg sites) are estimated These values differ from those previously repor­
ted 
Specifically bound [3H]TBOB is displaced bv Picrotoxin and by TBPS A simple 
competitive interaction of picrotoxm with ^HJTBOB binding is not found Micro-
molar quantities of the GABAergic facilitating compounds GABA. muscimol, diaze­
pam and pentobarbital, inhibit [3H]TBOB binding in an allostenc manner 
INTRODUCTION. 
The GABAA-receptor-complex is an ohgomenc membrane protem with 
allostenc bmding sites (Enna and Karbon, 1986, Stephenson, 1987) Ligand bindmg 
assays have demonstrated at least three distinct recognition sites at the GABAA 
receptor complex ι e a GABA receptor site, a benzodiazepine site and a picrotox-
irun or convulsant site (Bowery et al 1984, Olsen, 1981. Maksay and Simonyi, 
1986) A fourth binding site, a barbiturate recognition site, has been postulated 
(Tnfiletti et al, 1985) 
The picrotoxinin or convulsive site on the GABAA complex can be charac-
tenzed with [3H]-a-dihvdropicrotoxmm ([3H]DHP) (Ticku et al, 1978) and with 
[39s]_t_butylbicylophosphorothionate ([3!,S]TBPS, Maksay and Simonyi, 1986, 
Ramanjaneyulu and Ticku, 1984, Squires et al, 1983, Wong et al, 1984) A disad-
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vantage of using [3H]DHP is its low affinity (Kd _ 1-2 μΜ) and consequently its 
high non-specific binding A handicap of [3!5S]TBPS (Kd = 17-25 nMi is the short 
half life of the radiolabel Recentlv a new tntium labelled probe was introduced 
(3H]-t-butylbicydoorthobenzoate ((3H1TB0B) with a reported Kd of 60 nM 
(Lawrence et al, 1985) TBOB is structurallv related to TBPS 
As part of our study on the influence of convulsive compounds on the 
GABAA receptor complex, we determined the binding characteristics of [3H]TBOB 
and the interaction of the binding with a) GABAergic facilitating agents that 
produce anti-convulsant and sedative effects in vivo, and b) with GABAergic 
inhibitory agents Only a few reports using [3H]TBOB have been published 
(Lawrence et al 1985 O'Conner and McEwen, 1986 Fishman and Gianutsos 1987, 
Malmmen and Korpi 1988 Schwartz and Mindhn 1988) Only one report concerned 
the binding characteristics of [3H]TBOB (Lawrence et al 1985) In contrast to the 
data reported, we observed a high affimtv of [3H)TBOB (Kd - S nM), and a 
complex interaction of GABAergic drugs with [3Н]ТВОВ binding 
MATERIALS AND METHODS. 
Preparation of the Membranes. 
A crude membrane fraction was prepared as described by Lawrence et al 
(1985) Male Wistar rats (200 ± 20 g) were killed by decapitation The whole bram 
was weighed and homogemzed in 9 volumes 0 32 M sucrose at 0 0C with a Teflon-
glass homogemzer The homogenate was centnfuged at 1000 g for 10 mm at 4 "С 
the supernatant was decanted and centnfuged at 9000 g for 20 mm at 4 °C The 
pellet was suspended in 50 mM sodium-potassium-phosphate buffer, pH 7 4 con­
taining 500 mM NaCl (assay buffer) and centnfuged at 16000 g for 10 mm at 4 
0 C Protein concentration m the pellet was quantified bv the method of Lowry et 
al (1951) and was approximately 4 % of wet tissue weight 
Receptor Assays: General Procedure. 
Membrane pellets were resuspended in assay buffer Glass tubes (5 ml) 
received consecutively 100 μΐ of [3H]TBOB (specific activity 54 Ci/mmol Amer-
sham), 100 μΐ of buffer with or without competing hgand and 800 μΐ of tissue 
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homogenate (25 mg tissue) Incubations were performed at 25 'C usually lasting 45 
mm for saturation assays and W mm for inhibition assays Under these incubation 
conditions the stability of the compound was demonstrated by Scott et al (1987) 
Incubations were terminated by filtration of 0 8 ml of the incubation mixture 
through Whatman GF/B filters on a MiUipore 12 sample manifold The filters were 
washed two times with 5 ml ice cold buffer Radioactivity retained in the filters 
was counted by liquid scintillation spectrometrv Specific [:,H]TBOB bmdmg was 
defined as the différence between bmdmg in the absence and presence of 10 цМ 
Picrotoxin or 10 uM TBPS and was 60-70 % of total binding at 4 nM [3H]TBOB 
Experimental data were analyzed and binding parameters calculated by a computer 
assisted non linear least square curve fitting routine The kinetic data were 
analyzed by linear least square curve fittmg methods All data points are means 
of duplicates The methodology of analyzing the binding data is described by 
Bennett and Yamamura (1985) from whom we adopted the following methods 
Saturation Binding Assays. 
The concentrations of (3Н]ГВОВ ranged from 0 1 nM to 30 nM, m four 
expenments the concentration reached 60 nM 
Saturation binding assays for рЩТВОВ bmdmg were performed m the absence 
and presence of the tested inhibitors 
Kinetic Studies. 
For the kinetic studies fixed concentrations of 3H-TBOB were used 3 4 nM 
or 6 4 nM 
For association, mcubations were terminated after various tune intervals 
following addition of (3H]TBOB To determme the k*i, association was plotted 
according to the pseudo first order equation 
In {Вея / (Be, - Bt)} = ( b i L + k-i) t (1) 
m which Beq and Bt are the amount of [3H]TBOB-receptor complex in equilibrium 
and at tune t dunng incubation The k-i was determined from dissociation ex­
periments, L is the free ligand concentration and was approximately equal to the 
added concentration [3H]TBOB since at most 5 % of the [3H]TBOB added was 
bound 
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The half-life of association of second-order reactions is given bv the following 
equation 
U (ass) = In 2 / ( b i L + k-i) (2) 
For dissociation, membrane homogenates were premcubated with a fixed 
concentration of pHJTBOB (3 4 nM or 6 4 nM) at 25 0 C for 30 nun Dissociation 
was initiated bv 10 цМ Picrotoxin or 10 μΜ TBPS (time 0) РНІТВОВ binding was 
determined at vanous points of tune and plotted according to 
In (Bt / Веч) = - k-it (3) 
to yield the dissociation rate constant k-i and the halt-life of dissociation 
U (diss) - In 2 / k-i (4) 
The dissociation constant Kd of [3H]TBOB was determined by 
Kd = k-i / k n (5) 
Inhibition Studies. 
For inhibition studies a fixed concentration of [3HJTBOB of approximately 4 
nM was used We tested the following inhibitors a) the GABAergic facilitating 
ligands GABA, the GABA agonist muscimol, and diazepam .a GABA positive hgand 
for benzodiazepine binding sites and b) the GABAergic inhubitorv agents the 
GABA antagonist bicucullme, ethyl-ß-carbolme-3-carboxylate (ßCCE, a partiallv 
negative hgand for benzodiazepine binding sites) and the convulsants Picrotoxin 
and TBPS 
The binding affinity constants of the unlabelled ligands were estimated according 
to the following equation (Cheng and Prusoff,1973) 
Ki - ICso / (1 + L / Kd) (6) 
The unlabelled chemicals were obtained from Sigma except TBPS. which was 
obtained from NEN 
RESULTS. 
Binding Experiments. 
a) Saturation studies 
Fig 1 shows a representative curve of pHJTBOB binding to rat bram mem-
branes Specific binding was saturable and of high affinity A Scatchard represen-
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tation of the saturation isotherm (mset) points to a homogeneous population of 
binding sites Binding parameters of 16 independent experiments yield a mean 
equilibrium dissociation constant (Kd) of 7 7 + 2 0 nM and a total receptor density 
(RT) of 22 ± 5 pmol/g tissue corresponding to 0 56 ± 0 12 pmol/mg protein (mean 
± SD) 
Fig 1 
Binding curve of pHJTBOB to rat 
brain membranes, showing total 
binding ( · λ nonspecific binding 
(binding m the presence of 10 цМ 
picrotoxin)( о ), and specific binding 
(total binding minus nonspecific 
bindingXunmarked) as a function of 
pHJTBOB concentration Incubations 
were earned out at 25 °C Incubation 
time was 45 mm, tissue concentration 
was 25 mg/ml (Each data pomt is 
the mean of duplicates, the data are 
from a representative experiment) 
Inset Scatchard plot of the binding 
data 
b) Kinetic studies 
The association assay was performed at 6 4 nM (n-2) and 3 4 nM (n-2) free 
PHJTBOB concentration The dissociation assay was performed once at each of 
these concentrations Dissociation was initiated by 10 μΜ Picrotoxin or 10 uM 
TBPS Dissociation curves of specifically bound [эН]ТВОВ (fig 3) suggest a 
biphasic dissociation The small fast component (30 % of specific binding) has a 
dissociation rate constant (k-i) of 19xl0-3 s - 1 and a half life of dissociation 
t>i(diss) of 6 0 mm The slower component with a half life of 15 6 mm and a 
dissociation rate constant (k-i) of 7 4xl0-4 s - 1 constitutes 70 % of the binding 
Data points from the two dissociation experiments, each m duplicate, were 
analyzed simultaneously 
The association of [3H)TBOB to rat bram membranes is monophasic (fig 2) 
The association has a rate constant (k«i) of 1 9x10s M-'s"1 at 3 4 nM and 2 2x10* 
M"1s"1 at 6 4 nM, respectively (the slow component of dissociation was used to 
estimate k*i according to equation 1) The apparent association half life t«(ass) 
^Н T B O B bound (pmol/g) 
0 10 20 30 40 
3 H TBOB Iree(nM) 
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was 8.4 min at 3 4 nM and 5.3 min at 6.4 nM [3H]TBOB After 28 min and 18 min 
respectively, 90 % of the maximal receptor occupation was observed. A Kd value 
of 3.5 nM was calculated from the association and dissociation (slow component) 
rate constants. 
Ln |Beq /(B e q - Bt)l , L n ( B t / B e q ) 1 
0 10 20 30 0 10 20 30 ' 0 
t i m e imintjies) M m e (mmuies) 
Fig 2 
Semi-loganthmic transformation of association curves of [3H]TBOB binding at 6.4 
nM, AM- 2 2x10a M"1«-1 С) and 3.4 nM, к*і- 1.9x10a M-'s'1 ( A ) free 
[3H]TBOB concentration (Each data pomt is the mean of cwo experiments in 
duplicate Monophasic association is seen. Inset: In this transformation the as­
sociation rate constant is independent of dissociation and is equal to the slope of 
this ¡me: k*i- 9x10* M-'s-' (data are from the experiments for 3 4 nM). 
Fig 3 
Semi-loganthmic transformation of dissociation curves of PHJTBOB binding. 
Identical results are obtained when dissociation is initiated bv 10 μΜ Picrotoxin 
( О ) or by 10 μΜ TBPS ( Δ ;. Biphasic dissociation is seen Fast component. 30 
% of the bmding. t*,- 6 min. k-¡= 19xl0-3 s-1. Slow component: 70 % of the 
binding, fi- IS 6 nun. A'-i= 7 4xl0-'1 s-' (Each data point is the mean of dupli-
cates, all data points are analyzed simultaneously) 
Inhibition Experiments. 
Fig. 4 shows the inhibition of [3H]TBOB binding by GABA, diazepam and 
TBPS. ICso values of all ligands tested are listed in table 1. 
Analysis of [3H]TBOB binding in the absence and presence of the GABAergic 
facilitating compounds reveals a decrease in the apparent number of binding sites, 
without a change of the apparent affinity (table 2, fig 5). A decrease in the ap-
parent affinity of [3H]TBOB and a decrease of the RT were found in the presence 
of Picrotoxin (table 1, fig 5). 
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Table 1 ІСзо values of inhibitors of ¡3H]TBOB binding (PHJTBOB concentration 
4 nM) (mean ± SE) 
Compound 
Muscimol 
GABA 
Diazepam 
TBPS 
Picroloxin 
Bicuculline 
ßCCE 
η 
(5) 
(4) 
(4) 
(4) 
(11) 
(3) 
(2) 
ICso (μΜ) 
2.8 ± 0.8 
8.8 ± 1.5 
24 ± 3 
0.13 ± 0.02 
0.50 ± 0.03 
enhancement 
enhancement 
Slope Factor 
1.02 ± 0.16 
1.07 + 0.09 
0.66 ± 0.04 
1.12 ± 0.04 
1.04 ± 0.05 
3H TBOB Dirxj ng (%o( OTlrol 
100 tf"' 
0 *• 
Fig 4 
Inhibition curves of speciñc pHJTBOB binding by TBPS ( Ο λ GABA ( а ) , and 
diazepam ( •& ) TBPS and GABA displace pHJTBOB completely At the highest 
testable concentration of diazepam, ie 01 mM due to limited solubihty of the 
drug, 25 % of the specific binding was still present (Incubation time was 30 mm 
Data pomts are the mean of duplicates, non specific bmdmg was defined as 
pHJTBOB binding m the presence of 10 μΜ Picrotoxin) ІСзо values are listed in 
table 1 
Fig 5 
Scatchard analysis of [3H]TBOB 
bmdmg m the absence of modulat-
mg agents ( · Kd- S 4 nM Яг- 24 
pmoles/g), m the presence of 5 μΜ 
OABA (π Κα- 7 6 nM. RT- 15 
pmoles/g) and m the presence of 
0 5 μΜ Picrotoxin (о Kd- 11 nM, 
RT= 13 pmoles/g) (representative 
curves of at least four similar 
results, see table 2, each data point 
is the mean of duplicates, mcuba-
tion time is 45 mm) 20 25 
bound (pma/g) 
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Table 2 Apparent PHJTBOB binding parameters m the presence of the indicated 
amounts of inhibiting compounds The saturation e\peninents were conducted in 
pan ed assa\s with conti ois in the absence of the inhibiting compound The 
control values are given m parenthesis Seven concentrations (3H]TBOB varying 
from 0 1 to 30 nM wei e used 
Compound 
concentration η 
Muscimol I.IO-6 M 1 
GABA 5.10-β M 4 
Diazepam 5.10-' M 1 
Picrotoxin 5.ΙΟ-7 M 4 
Kd (nM) 
(exp)(control) 
6.6 ( 7.1) 
8.7 ( 8.8) 
6.4 ( 7.1) 
10.2 ( 7.2) 
RT (pmol/g) 
(exp)(control) 
5 (24) 
12 (25) 
8 (24) 
10 (22) 
for η ^2 paired Student-t-test 
1) GABA n~4 Kd not sigmfícantlv different from control p^O 1 
RT significantly different from control p^O 01 
2) Picrotoxin n-4 Kd significantly different from control p<0 05 
RT sigmfícantlv different from control p\0 01 
DISCUSSION. 
Binding Parameters. 
The affinity of [3H]TBOB for rat brain membranes was determined m two in-
dependent ways by saturation analysis and by analysis of the data from kinetic 
studies Both independent expenmental approaches reveal affinity values of the 
same magnitude Kii-7 7 nM and Kci(slow diss)-3 5 nM The method to estunate the 
association rate constant takes into consideration the contnbution of dissociation. 
as is seen in equation 1 If the fast component of dissociation is substituted in 
equation 1, negative association rate constants are obtained and no corresponding 
Kd values can be calculated In an alternative analysis of the kinetic data, only 
datapomts up to the first half life tune are taken into account For these points 
dissociation is still negligible and the following equation holds true 
1 RT ( L - Bt ) 
In = k*i t (7) 
L - RT L ( RT - Bt ) 
RT IS the receptor concentration and was estimated from the saturation experi-
ments By plottmg the left part of equation 7 as a function of time (fig 2, inset) 
k+i can be estimated to be (0 9 ± 0 3)xl03 M-'s - 1 (mean ± SD, n-4), correspond-
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ing with Ka values of 8 nM and 20 nM for the slow and fast dissociating com-
ponent respectively 
Saturation analysis (Scatchard plots) indicates only one population of binding 
sites (K(i=7 7 nM) Kinetic analysis suggests the presence of an additional lower 
affinity receptor site K<i(fast diss)=20 nM A possible explanation for this dis-
agreement could be that the maximal concentrations [3H]TBOB are too low to 
reveal the higher Kd Moreover, the affinities as calculated from kinetic studies 
may be too close to be differentiated by Scatchard analysis 
Lawrence et al (1985) found from saturation experiments a Kd value of 60 nM, 
which is considerably higher than the values reported here In addition these 
authors report t^ass) and ti4(diss)(fast & slow) deterrmned from kinetic expen-
ments but unfortunately they did not determine Kd values from these data 
Calculating the Kd values from the half hfes given by Lawrence et al (1985) bv 
using the equations 2 4,5 given m Materials and Methods, values of 1 4 nM and 4 
nM are obtained These values are not m agreement with the Kd determined from 
Lawrence's saturation expenmems but they are closer to the Kd values reported 
here 
Inhibition studies. 
The present study supports the assumption that [3H]TBOB labels a site 
associated with the GABAA-receptor complex 
The GABAergic facilitating agents tested displace [3H]TBOB binding The 
GABAergic inhibitory ligands bicuculline and ßCCE do not displace [3H]TBOB in 
concentrations up to 0 1 mM, in contrast an enhancement of the binding was 
observed to 166 ± 5 % (n-3, mean ± SD) of control in the presence of 10 μΜ 
bicuculline, to 121 ± 7 % in the presence of 0 1 μΜ (JCCE (n-4, mean ± SD) These 
observations are in agreement with those of Gee et al, (1986) who demonstrated 
this effect on [353]ΓΒΡ3 binding for PCCE Moreover, Squires and Saederup (1987) 
reported a number of GABAA receptor blockers to be able to enhance [3'S]TBPS 
bmdmg, m the presence of GABA though As our membrane pellets are washed 
once only, it is likely that some endogenous GABA is still present in the incuba­
tion mixture (Van Rijn et al 1988) 
The ІСэо values of the GABAergic facilitating ligands should be interpreted in 
view of this probability as well The observed ICao value of GABA is 8 8 μΜ It is 
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likely that the allosiencallv induced changes of TBOB sites are modulated bv 
GABAergic hgands via ihe low affinitv sites ot üABA (licku and Ramanjanevulu 
1984) 
The enhancement ot |3H]TBOB binding bv GABA inhibitory compounds is not 
mimicked bv those GABAergic inhibitorv hgands that are thought to act on the 
convulsant site directly, ι e Picrotoxin and TBPS, thev inhibit [3HlTBOB binding 
Saturation analvsis shows that the GABAergic facilitating hgands do not 
affect the apparent affinitv of рЩТВОВ, but they appear to decrease the number 
of binding sites of TBOB such as those of TBPS (Wong et al ,1984) The existence 
ot separate but allosiencallv interacting, binding sites for TBOB, GABA, and 
benzodiazepines in the GABAA receptor complex must be assumed 
Picrotoxin lowers the apparent affinitv of [3Н]1ВОВ as well as the apparent 
number of binding sites Two explanations mav be possible Picrotoxin binds more 
rapidly than [3H]TBOB and [3H]TBOB can not completely replace it or Picrotoxin 
and TBOB do not bind to identical sites in a simple competitive manner Tehram 
et al (1985) found two binding sites for ["SITBPS with Kd values of 1 15 nM 
and 232 nM The ICso value of Picrotoxin for the inhibition of [3H]TBOB binding 
reported here (0 50 μΜ) corresponds to the ІСзо value of picrotoxm for the 
inhibition ot low affinitv [3SSJTBPS sites reported bv Tehram et al (1985) (ie 
0 56 μΜ), suggesting that the Picrotoxin bindmg sites correspond to the descnbed 
low affinitv [3!IS)TBPS binding sites 
The high affinitv of [3H]TBOB and its interaction with the above mentioned 
binding sites makes the ligand very valuable in studying the GABAA receptor-Cl--
lonophore 
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FOLATES: EPILEPTOGENIC EFFECTS 
AND ENHANCING EFFECTS ON 3H-TBOB BINDING 
TO THE GABAA RECEPTOR COMPLEX 
С M van Rijn, Τ J Α M van der Velden, 
J F Rodngues de Miranda, 
M G Ρ Feenstra, J A P Hiel, O R Hommes 
SUMMARY. 
The biochemical mechanism responsible for the convulsive effects of folates was 
investigated The epileptogenic effects of folates were determined in vivo bv 
quantification of the seizures following mtracortical application in rats The rank 
order of epileptogenic effects is 
folic acid t 5-HCO-H4folate > Hîfolate > S-CHs-H^folate, 
This sequence of epileptogemcitv in vivo is compared to the rank order of the 
effects of the above folates on radioligand binding to the GABAA-receptor-
complex in vitro The mhibitorv potencies of folates on 3H-muscimol and 3H-
diazepam bindings did not correlate with their epileptogenic effects However, 
folates reverse the inhibiting effect of GABA on the binding of the cage convul-
sant 3H-TBOB (3H-t-butylbicycloorthobenzoate) The rank order of this in vitro 
effect (folic acid > 5 HCO-^folate > Hzfolate = S-CHs-H^folate), correlates with 
the rank order of epileptogemcitv determined in vivo A relationship between the 
in vivo and in vitro effects is therefore suggested 
INTRODUCTION. 
Folic acid can evoke epileptic phenomena when it penetrates into the 
brain16· 17' "• 2e The biochemical background of this action is unknown A 
direct action of folic acid on synaptic receptors was proposed by Davies and 
Watkins" Hill and Miller13 provided an electrophysiological indication of such an 
action, namely the antagonizing of synaptic inhibition Otis et al specified this 
suggested folate action to a blockade of the GABA response (in electrophysiologi-
cal studies as well)31 
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Following the suggestions of a direct receptor action of folic acid the 
epileptic phenomena caused by folic acid were compared to those of known disrn-
hibitorv and excitatory substances (Chapter 2) It has been found that the epilep-
tic phenomena induced by folic acid resemble closely those induced by bicucullme 
and strychnine penicithn1 and Picrotoxin3 but differ in many respects from those 
induced by kaimc acid2· 26' 39· 40 carbachol and neostigmine (Chapter 2) These 
findings support the suggestion that folic acid is blocking the inhibitory system 
rather than potentiating the excitatory system An additional indication of this 
hypothesis was reported by Herrón et all1Э who found on hippocampal slices a 
difference of epileptiform responses induced by folic acid and bicucullme compared 
to kauuc acid An effect of folic acid on an excitatory ammo acid receptor was 
suggested by Stephens et allЭ7 but from this in vivo study a discrimination 
between excitation and dismhibition on the neuronal level may not be made In 
conclusion there are indications that folic acid blocks the inhibitory system 
GABA ( γ-Ammobutvnc acid) is considered to be a major inhibitory neuro­
transmitter in the central nervous system (overview Enna and Karbon10) The 
GABAA-receptor complex is an ohgomenc membrane protein with allostenc binding 
sites38 Ligand bmdmg assays have demonstrated at least three distinct receptor 
sites at the receptor complex ι e GABA receptor sites (high- and low-affinity), 
benzodiazepine sites and picrotoxmm or convulsant sites'· 2 9 a fourth, a bar­
biturate recognition site, has been postulated20· 4 1 
We tested the influence of folic acid on three components of the GABAA-
receptor complex in vitro the high affimtv GABAA site, labeled with ^ - m u s ­
cimol, the benzodiazepme site, labeled with 3H-diazepam and the Picrotoxin- or 
convulsant site labeled with 3H-TBOB (3ΐΙ t butylbicycloorthobenzoate) 
The epileptogenic effects of folic acid can be evoked by derivatives of folic 
acid as well28 Presently we report a sequence of epileptogemcity of four tested 
folates4 folic acid 5-formvl-tetrahvdrofolate (S-HCO-H^folate), dihvdrofolate 
(Hjfolate) and 5-methyl-tetrahydrofolate (S-CHs-H^folate) We compared the rank 
order of m vivo effects and in vitro effects on the GABAA-receptor complex 
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MATERIALS AND METHODS. 
In vivo experiments. 
Subjects. 
Male Wistar albino rats were used with a weight of 200 ± 20 g at time of surgery. 
The animals were individuallv housed and allowed access to food and water ad 
libitum. A 12 h light, 12 h dark cycle was maintained. The experiments took place 
in the light phase. 
Surgery. 
The animals were anaesthetized by pentobarbital i.p. A polyethylene cannula (outer 
diameter 0.8 mm, inner diameter 0.4 mm) was implanted through a drill hole in 
the scull: 1.4 mm to the nght of bregma, where the sensorimotor cortex of the 
left hmdleg is situated The cannula was fixed bv acrvlic cement. The tip of the 
cannula was 2.0 mm beneath the upper surface of the scull. Histological examina­
tion revealed that the tip was in lamina IV or V of the cortex. The cannula could 
be connected to a flexible injection system, thus permitting free movement during 
administration of the drugs. The animals were left to recover from surgery for 5 
to 7 days. 
Observations. 
The folates, dissolved in distilled water, were injected through the cannula in a 
volume of 0.5 - 2.0 μΐ, with a rate of 0.5 μΐ/min. One test per day was conducted. 
Folic acid was tested on all animals, each folate derivative was tested on a 
group of 8-10 animals, alternated the next day by folic acid which was our 
control for the day dependency of the response. In a pilot study we had deter­
mined the amounts of folate necessary to produce visible jerks. In the present 
study we tested: for folic acid and 5-HCO-H4folate: 5 nmoles and 10 nmoles, for 
H2folate: 25 nmoles and 50 nmoles, for SCHa-Hifolate: 50 nmoles and 100 nmoles. 
The animals were observed for 1.5 h following injection of folate. The observation 
included the registration of the total duration of the epileptic events, the number 
of general seizures, the classification of the extension and the intensity of the 
myoclonic events (see table 1) and the counting of the jerks in four periods of 5 
minutes, with intervals of 10 minutes (10-15, 25-30, 40-45 and 55-60 minutes). 
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In vitro experiments. 
Membrane preparation. 
Crude synaptic membrane fractions were prepared from whole brains of albino 
Wistar rats weighing 200 ± 20 g The brains were quicklv removed after sacnfice 
by cervical dislocation and homogeni7ed in 0 32 M sucrose at 1 10 weight/vol­
ume ratio with a Potter homogenizer with a teflon pestle for 5 sec at 600 ф т 
The sucrose homogenates were centnfuged at 1000 g for 10 mm (all centnfuga-
tions were earned out at 4 °C) The supernatant fractions were decanted (A) 
3H-Muscimol and 'H-Diazepam preparations 
The supernatant (A) was recentnfuged at 20 000 g for 20 mm , the resulting 
pellet was resuspended in ice-cold water for 15 mm (osmotic shock) and 
then recentnfuged at 8000 g for 20 mm The supernatant and the buffy coat 
were removed, centnfuged at 48,000 g for 20 mm and the final pellet was 
stored at -20 "C for at least 24 hours (B) 
3 H - Muscimol preparation9 " 
After thawing the pellets (B) were treated with 20 volumes of 0 025 % 
Tnton X-100 in 50 mM Tns HCl buffer, pH 7 1, for 30 mm at 37 0 C 
and then centnfuged at 50 000 g for 10 mm The resulting pellets were 
washed three times by resuspending them in 50 mM Ins-HCl, pH 7 1 
and centnfugation at 50,000 g for 10 mm The final pellet was resus­
pended in the same buffer at a final tissue concentration of 15 mg/ml 
'H-Diazepam preparation6· 7 
After thawing, the pellets (B) were washed three times in 50 mM Tns-
HC1 buffer, pH 7 7 by centnfugation at 50 000 g for 10 mm The final 
pellet was resuspended m the same buffer at a final tissue concentra­
tion of 25 mg/ml 
'H-TBOB preparation19· *· 
The supernatant (A) was centnfuged at 9000 g for 20 min, after which the 
pellet was washed once by resuspension in 50 mM sodium potassium-phos­
phate buffer, containing 500 mM NaCl, followed by centnfugation at 16,000 g 
for 10 mm The final pellet was resuspended in the same buffer at a final 
tissue concentration of 25 mg/ml 
Protein was quantified by the method of Lowry21 
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Binding assays 
Aliquots of the synaptic membranes suspensions (0 5-10 ml) were added to glass 
tubes together with the radioligand in the absence or presence of nonlabeled test 
compound 
bxpenments were run in senes with control samples, blanks containing excess of 
nonlabeled competitive hgand to determine nonspecific binding, and test samples 
in duplicates or tnphcates Incubations were terminated bv filtration of aliquots 
of the incubation mixture through Whatman OF/B filters on a Millipore 12 sample 
manifold The filters were washed two times with 5 ml ice cold buffer Radioac­
tivity retained on the filters was counted bv liquid scintillation spectrometry 
Expenmental data were analyzed and binding parameters calculated bv a computer 
assisted non-linear least square curve fitting routine The kinetic data were 
analyzed by linear least square curve fitting methods 
3H-Muscimol assays9· ^ 
Incubations with 3H-muscrmol (spec act 57 Ci/mmol)were performed at 0 CC 
for 30 mm In saturation binding assays, ^H muscimol concentration ranged 
from 0 5 to 20 nM The inhibition studies as well as the kmetic studies were 
performed with a constant radioligand concentration of 1 nM Specific 3 H 
muscimol binding was defined as the difference between binding in the 
absence and presence of 10 μΜ OABA or 10 μΜ muscimol and was approxim­
ately 80 % of total bmding at 1 nM 3H-muscimol 
3H-Diazepam assays6, 7 
The mcubation conditions of 3H-diazepam (spec act 85 Ci/mmol) were at 
first 20 mm at 37 "с, then an additional 15 mm at 0 CC This procedure 
increases specific binding6 In saturation bindmg assays, 3H-diazepam con­
centration ranged from 1 0 to 25 nM The inhibition and kinetic studies were 
performed with a radioligand concentration of 2 5 nM Specific 3H-(iiazepam 
binding was determined in the presence of 10 μΜ unlabeled diazepam and 
was approximately 85 % of total binding at 2 5 nM radioligand 
3H-TBOB assays19· 3* 
Incubations with 3 H TBOB (spec act 46 Ci/mmol) were performed at 25 0 C 
for 45 mm for bindmg assays and 30 mm for mcubation assays In the 
saturation binding assays the concentrations of 3H-lBOB ranged from 0 1 nM 
to 100 nM The inhibition and kinetic studies were performed with a radio-
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ligand concentration of 4 nM Specific 3H-TBOB binding was defined as the 
difference between binding in the absence and presence of 10 |iM Picrotoxin 
or 10 μΜ TBPS and was 60-70 % of total binding at 4 nM 3H-TBOB 
Concentration-response curves were mad? for the folates in the absence and 
presence of 5 цМ GABA Six or seven concentrations of the folates were 
used, varying from 1 μΜ to 1 mM 
Chemicals. 
The radioligands were obtained from Amersham, England The nonlabeled 
hgands were obtained from Sigma England except for TBPS, which was delivered 
by NEN Germany 
RESULTS 1 : In vivo experiments. 
Behavioral effects of the folates in general 
Injection of the described amounts of the vanous folates mto the senson-
motor cortex of the rat produced muscular contractions We observed no abnor­
malities after Injecting a physiological NaCl solution The muscular contractions 
were clearly observable myoclomc jerks, varying from a slight extension of one of 
the toes to an abrupt strong flexion movement in knee and hip combined by axial 
turning The extension of the jerks was sometimes restncted to the hmdleg, but 
often the forelunb, ear and eyelid were involved too Contralateral jerking was 
seen as well The spread and intensity of the jerks could not be quantified 
reliably, due to their continuously changing pattern Median values of the maximal 
intensity- and extension values are given in table 2 
Apart from the myoclonic jerks some generalized seizures were seen, lasting 
a few seconds only (table 2) No other behavioral abnormalities were observed 
consciousness was unimpaired and grooming behavior was normal (the generalized 
seizures excepted) 
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Behavioral effects of the folates: rank order. 
The jerking started within 5 minutes after injection, lasting for about one 
hour (table 2) A significant difference in duration between folic acid and 5-HCO-
Hifolate at the 5 nmoles dose but not at the 10 nmoles dose was observed 
(Wilcoxon test at the p-0 05 level) 
The number of jerks is given in table 2 The results of folic acid on the 
first test day are given No difference between the equimolar doses of folic acid 
and S-HCO-H^folate was observed and no difference between data of folic acid on 
the first dav and folic acid on the control days was observed (data not shown) 
(Wilcoxon p>0 05) A rank order of epileptogenic effects was denved from table 2 
Folic acid ì S-HCO-H^folate > Hzfolate > S-CHa-IWolate 
Table 1 Classification entena of the mvoclonic contractions 
Extension 
Class/visible motor effect in: 
1 only left hindlunb 
2 left hindlimb and forelunb 
3 both lelt limbs + face 
4 contralateral 
Intensity 
Class/motor effect resulting in: 
1 jerking without lifting the limb 
2 jerking with lifting the lini) 
3 associated axidl turning 
4 rolling си the back 
Table 2 Classification and quantification of the epileptic phenomena 
folate 
Folic acid 
5-H00-H,folate 
Нг folate 
S-Ofa-H, folate 
η 
28 
8 
10 
10 
doses 
(racles) 
5 , 10 
5 , 10 
25 , 50 
50 ,100 
max intensity class 
median (range) 
2 (1-3) , 3 (1-4) 
2 (2-3) , 3 (2-3) 
2 (1-3) , 2 (1-4) 
2 (1-3) , 1 (1-3) 
max extension class 
median (range) 
2 (1-3) , 3 (1-3) 
2 (1-3) , 3 (1-3) 
1 (1-3) , 2 (1-3) 
1 (1 3) , 1 (1-3) 
folate 
Folic acid 
5-HCO-H4folate 
Нгfolate 
5-ab -Infoiate 
duration of jerks 
(minutes) mean+SD 
60 ± 14 , 76 ± 18 
44 ± 16 , 66 ± 17 
54 ± 17 , 75 ± 22 
45 ± 21 , 53 ± 19 
nmiier of jerks 
(1/20 m m ) mean+SD 
315 ± 205 , 527 ± 235 
273 ± 166 , 571 ± 175 
213 ± 141 , 302 ± 97 
98 ± 52 , 202 ± 148 
generalized 
seizures 
(1 rats/tt group) 
2/8 , 4/8 
1/8 , 4/8 
0/10 , 2/10 
0/10 , 0/10 
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RESULTS 2 : In vitro experiments. 
Binding-parameten of the radioligands. 
Saturation analysis reveals nM affinity binding of 3H-muscimol (Kd 5.2 ± 1.3 
nM. mean + SEM, n=10), 3H-diazepam (Kd 17 ± 5 nM, n-7) and 3H-TBOB (Kd 7.7 
± 2 0 nM, n=16). The Kd values found are in general agreement with previously 
published reports6· 7· »· "• «, except for 3H-TBOB The Kd value of 3H-TBOB 
appears to be lower than the result reported before1' (i.e. 60 nM). In a separate 
study in which the binding behavior of 3H-TBOB was evaluated in detail, the low 
Kd value has been confirmed (Chapter 5). Displacement expenments with known 
GABA-ergic compounds as well as enhancement data on 3 H diazepam binding are 
consistent with previous reports as well6· 1· 2 9. The results of the displacement 
studies are given in table 3. GABA and muscimol enhanced the binding of 3H-
diazepam: GABA (50 μΜ) to a maximum of 150 + 7 % of initial binding (mean ± 
SEM, n-8), muscimol to 190 % of initial binding (n=l). Pentobarbital enhanced the 
binding of 3H-diazepam as well, to 180 % of initial binding at the highest dissolv­
able concentration of 1 mM, n-1. 
Table 3. ІСзо and ЕСзо values of tested compounds. (Legends see next page) 
Ligand 
Ccnqpound 
Muscimol 
GAM 
Bicuculline 
BicucullineMCl 
Dia7epam 
&CCE 
Picrotoxin 
TBPS 
Pentobarbital 
Folic acid 
5-HCO-H4folate 
№ folate 
S-Ob-tti folate 
1 nM 3H-Musciirol 
μΜ %SD η 
.0035 1 
.049 42 6 
3.8 18 3 
34 1 
>100 1 
nd 
)1000 1 
nd 
nd 
4 
220 18 J 
2 
2.5 nM 3H-Diazepam 
μΜ %SD η 
t .5 1 
t 1.4 21 5 
>100 1 
>100 1 
.014 36 7 
.0013 43 4 
>1000 2 
nd 
t * 2 
230 17 6 
1476 2 
230 2 
1467 17 1 
4 nM 3H-TB0B 
μΜ %SD η 
1.1 18 5 
7.7 19 4 
t .18 17 3 
t .20 1 
39 5 4 
t .02 50 3 
.50 6 11 
.10 22 5 
41 12 2 
t * 20 
t * 10 
t * 5 
t * 5 
68 
In Vitro: Folate Influence on the OABAA Complex 
Table 3 
Displacement ІСзо values and enhancement ЬСяо values of the tested compounds 
for the three radioligands used Binding conditions are descnbed m Materials and 
Methods 
Values are given m μΜ SD the standard deviation given as a percentage of the 
ICso value η the number of e\penments m tnphcates (3H-muscimol) or dupli­
cates (3H-diazepam and 3H-TB0B) nd not determined 
t no inlubition but an enhancement of the radiohgand binding is observed * no 
saturation was obsen ed ai the highest dissolvable concentration ι e 1 mM The 
data of the folates for 3H-inuscimol were analvzed simultaneously (see fig 1) For 
JH-diazepam the data of fohc acid and НгІоШе were analvzed simultaneously as 
well as the data of S HCO-H4folate and S-Cfa-Hifolate (see fig 2) 
Folate influence on the binding of the radioligands. 
- The folates did displace bound 3H-muscimol but no significant difference 
between the folates was observed (Analysis ot vanance F3 64 = 0 38, p>0 7, fig 1, 
table 3) The ICso was 220 μΜ the slope factor was 0 64 
The folates did displace 3H-diazepam binding as well \ significant difference 
between the folates was found (F3,68 - 8 70 p<0 05) Scheffe's post hoc analysis 
revealed no difference between folic acid and Infoiate (ICso 230 μΜ, slope factor 
0 62) and no difference between 5-HCO-H4folate and 5-СНэ-Мо1аІе (ICso 1476 
μΜ, slope factor 0 68) (fig 2, table 3) 
- GABAergic facilitating hgands displaced bound 3H-TBOB with micromolar 
potencies The convulsants ТВ PS and Picrotoxin displaced the radioligand as well 
The GABAergic inhibitory compounds bicuculline (a GABAA antagonist) and ßCCE 
(an inverse agonist of benzodiazepine receptors) however enhanced the binding of 
3H TBOB Bicuculline (5 μΜ) enhanced the binding to 169 + 4 % of initial binding 
(mean + SEM, n-3) and ßCCE (1 μΜ) to 118 + 5 % (n-3)(table 3) Higher con­
centrations of bicuculline and ßCCE inhibited 3H-TBOB binding (data see Ch 8) 
The folates enhanced the binding of 3H-TBOB as well (fig 3) In the absence 
of GABA this enhancement was obvious for folic acid at a concentration of 0,5 
mM folic acid the binding is 140 ± 6 %, n-28, mean ± SEM) For the other folates 
tested the enhancement was less A significant difference between the folates was 
found (F3,184 - 12 12 p<0 01) In Scheffe's post hoc analysis folic acid differed 
from the other three folates at the p-0 05 level No difference between the latter 
three folates was found 
The enhancing effects of the folates increased relatively in the presence of 
GABA In the presence of 5 μΜ GABA (initial binding was 65 % of control, fig 4 
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left ordinate) folic acid produced an enhancement to 220 % of initial binding (fig 
4, nght ordinate) The enhancing effect of 5-HCO-H4folate under this condition 
was slightly less 190 % whereas the enhancements by Hsfolate and S-Cbb-Hafo-
late were less, reaching a 140 % of GAB A control only Analysis of variance has 
been performed The difference between the folates is highly significant (F3 75 -
73 46, p<0 001) Post hoc analysis reveals a difference between folic acid and the 
other three folates as well as a difference between S-HCO-FUfolate and the other 
folates No difference between Hzfolate and S-CHa-bWolate was observed 
In conclusion the rank order of 3H-TBOB enhancing effect of the folates in 
the presence of GABA 
Folic acid > S-HCO-fM 
Fig 1 
Displacement curves of specific 3H-
muscimol binding by folic acid 
( · ), 5-HCO-H4folate ( С ). 
Hífolate ( m ) and S-CHs-frfolate 
( π ) Each data point is the mean 
of at least two independent measu­
rements m triplicate see table 3. 
bar is 1 χ SD No significant dif­
ference between the folates was 
observed analysis of variance 
F3M = 0 38, p>0 7 ICSO 220 uM, 
Slope factor 0 64 
Fig 2 
Displacement curves of specific 3H-
diazepam binding by folic acid 
( · ), S-HCO-H<foIate ( О info­
iate ( m ) and S-CHa-Hifolate (Ώ ) 
Each data point is the mean of at 
least two mdependent measurements 
m duplicate see table 3, bar is 1 χ 
SD No significant difference 
between fohc acid and Hzfolate was 
observed ІСзо 230 μΜ, Slope factor 
0 62 A significant difference 
between folic acid compared with 
S-HCO-Hifolate and 5- Clh-H*folate 
was observed ICso of the latter 
two 1467 μΜ, Slope factor 0 68 
Analysis of variance F3,68 = 8 70, 
p<0 05) and Scheffe's post hoc 
analysis ICx values are listed m 
table 3 
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Fig. 3 
Effect of vanous concentrations of 
folic acid ( · λ 5-HCO-H4folate 
( О t.Hzfolate ( m ) and 5-СНз-
Hi folate ( π ) on ^H-TBOB binding 
(4 nM) m the absence of exogenous 
GABA. Each data point is the mean 
of at least fíve independent measu-
rements in duplicate, bar is 1 χ SD. 
The folates enhance 3H-TBOB 
binding (F5,1S4 - 6 Π; ρ-,Ο.ΟΙ). 
A significant difference between 
the folates was found (F3,184 -
12.12; p^O.Ol). In Scheffe's post hoc 
analysis fohc acid differed from the 
other three folates at the p-0.05 
level. No difference between the 
latter three folates was found. 
3
И - Т В О В binding (%ol c o n l r o l l 
1 / 
^ 1-
1- f 
^ 
, 1 
1 3 
? 
log t o l t i l e !M> 
H-TBOB binding (%of control) 
Fig. 4 
Effect of various concentrations of 
the folates on 3H-TBOB binding (4 
nM) in the presence of 5 μΜ GABA 
(65 % of control bindmg)(folic acid 
< m ), 5-HCO-H4folate ( О ),Шо-
late ( m ) and S-CHs-Hifolate 
( α )). Each data point is the mean 
of four independent measurements 
in duplicates, bar is 1 χ SD. 
The folates differed significantlv 
<F3,75 - 73.46; p<0.001). Post hoc 
analysis revealed a difference 
between folic acid, S-HCO-Hifolate 
and the other two folates. No 
difference between Hzfolate and 5-
CHi-Hifolate was seen. 
I 
(%o< initial binding) 
1 -225 
V \ 
ioq І О І Я І Р W 
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DISCUSSION 
In the rat mtracortical application of fohc acid produces muscular contrac­
tions We have shown bv ECoG recordings that these motor phenomena resemble 
epileptic events1 (Ch 2) The epileptic events can be evoked by folate derivatives 
as well The rank order of folates to induce the epileptogenic jerks we report is 
in general agreement with our previous studies, in which we used a different 
technique to induce and to quantify the epileptic phenomena28 
The present study tried to determine whether the GABAA receptor complex is the 
pnmarv site of interaction responsible for the epileptogenic action of the folates 
Folates displace both 3H-muscimol and 3H-diazepam with comparable af­
finities and no clear differentiation between the folates is found in interaction 
with either of these binding sites It is therefore not likely that an interaction 
of the folates with the high affinuy GABAA site or with the benzodiazepine site 
of the GABAA receptor complex can account for the epileptic phenomena 
In chapter 7 we will show that folic acid reverses the inhibitory effect of GABA 
on
 JH-TBOB binding42 Here we report that all four tested folates reverse the 
GABA suppression of 3H-TBOB binding Moreover, the rank order of epileptogenic 
activity in vivo corresponds to the rank order m reversing the inhibitory action 
of GABA in vitro on эН-ТВОВ binding Therefore it seems reasonable to assume 
3 
that the enhancement of H-TBOB binding by folates in the presence of pmolar 
GABA can account for the epileptic phenomena 
This assumption is supported by the following observations 
3 
1 The folate concentrations reversing the inhibitorv effect of GABA on H-
TBOB binding (10 μΜ to 1000 μΜ) are m agreement with the effective folate con­
centration measured in vivo following mtracortical injection of 5 nmoles of folic 
acid the concentration m the brain near the cannula is 20 μΜ -100 μΜ (Ch 2), 
the folic acid concentration after mtravenous injection (after a focal lesion of the 
blood brain bamer) has a value of 150 μ M in the focus17 
2 Herrón et al needed a bath concentration of 500 μΜ folate to evoke popula­
tion spikes in hippocampal slices13 
From 1 and 2 we conclude that the epileptogenic folate concentration in vivo is 
m agreement with ihe effective concentration in vitro 
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3 The concentration of GABA that has to be added to observe the rank order 
of in vitro effects of the folates is of the same range as the concentration of 
GABA in functional expenments GABA increases the CI permeability at a con 
centration of about 10 μΜ1 Β 
4 Folate induced seizures resemble those induced by bicuculline, a hgand 
labeling selectively the low affinitv GABAA sites having micromolar affinity for 
GABA (Kd - ΙμΜ) 3 0 
5 The presence of anions such as CI" remove the high affinity population of 
GABA binding sites, leaving the low affinity population22 We used 500 mM NaCl 
to optimize JH-TBOB binding34· з* 
From 3 - 5 we conclude that the GABAA low affinity binding site is probably 
influenced by the folates 
3H-TBOB was only recently introduced, only a few reports on interactions 
with the other binding sites of the GABAA complex are available yet19- 2!>' 3 3 
The effects may be compared to reports on 3!,S-TBPS bmding interactions23 2 4 ' 
32, 43 ^ number of GABAergic inhibitory compounds in electrophysiological 
systems reverse (partially) GABA suppression of 33S-TBPS binding11· 1 2 ' 3 ' It has 
been suggested that reversal of the inhibitory effect of GABA on 33S TBPS 
binding is a method for assessmg the seizure inducing liability of drugs33· 3 6 The 
results of the present study support this suggestion 
CONCLUSION. 
The rank order correlation of the tested folates for the ability to enhance 
3H-TBOB binding to rat brain membranes in vitro in the presence of GABA and to 
induce myoclonic jerks after intracortical application, suggest a possible relation­
ship between folate induced receptor interactions within the GABAA receptor 
complex and folate induced epileptic phenomena 
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THE INFLUENCE OF FOUC ACID ON 
THE PICROTOXIN SENSITIVE (CONVULSANT) SITE OF 
THE OABAA RECEPTOR COMPLEX 
С M van Rijn, Τ J A M van der Velden, 
J F Rodrigues de Miranda, M O P Feenstra, O R Hommes 
SUMMARY. 
The site of action responsible for the convulsive effect of folic acid was 
investigated in vitro Folic acid (ECmax SxlO-4 M) enhances the binding of the 
cage convulsant ('Hj-t-butylbicvcloorthobenzoate (3H-TBOB) to rat brain mem­
branes. namely to 130 % of control in the absence of GAB A and to over 300 % of 
control in the presence of physiological concentrations of GABA Analysis ol the 
binding parameters reveals that folic acid increases the apparent number of 
3H TBOB binding sites 
INTRODUCTION 
Folic acid can evoke epileptic phenomena when it penetrates mto the brain, 
as is known since the sixties [3,7] The biochemical background of this action is 
still unknown A direct action of folic acid on synaptic receptors was proposed by 
Davies and Watkins in 1973 [1] The very next year, Hill and Miller [2] provided 
an electrophysiological indication of such an action, namely the antagonizing of 
synaptic inhibition It was not until 1985 that a second report with electrophysio­
logical evidence of a direct synaptic action of folic acid was pubbshed a blockade 
of the GABA response [8] The finding that the epileptic phenomena induced by 
folic acid resemble closely those induced by the GABA-antagomst bicuculline [Ch 
2], but differ in many respects from those induced by the excitatory kainic acid 
[11], supports the suggestion that folic acid affects the inhibitory GABA system 
Recently an effect of folic acid of a different nature, viz on an excitatory amino 
acid receptor was reported [10], but this in vivo study cannot exclude disin-
hibition on the neuronal level We tested the influence of folic acid on various 
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components of the GABA receptor-Cl-ionophore (Ch 6) We report here the 
influence of folic acid on the convulsant site of the complex 
METHODS. 
The characterization of the convulsant (Picrotoxin sensitive) site was per­
formed according to Lawrence et al |6] with pHJ-t-butylbicycloorthobenzoate 
('H-TBOB. specific activity 54 Ci/mmole. Amersham) Homogenates of brains of 
male Wistar rats (200 ± 20 g) were used Crude synaptic membranes (P2 pellets) 
were suspended in 0 05 M sodium-potassium-phosphate buffer pH 7 4, containing 
0 5 M NaCl [6,9] In this buffer the pellets were washed once 3 H TBOB (+ 4xl0-9 
M) was incubated in the absence or presence of varying concentrations of folic 
acid GABA, or both (Sigma) Saturation binding assavs with 3H-TBOB concentra­
tions varying from 0 IxO"9 M to ЗОхЮ-' M, were performed m the absence or 
presence of constant concentrations of folic acid and/or GABA 
Incubations were at 25 "C for 30 mm (inhibition studies) or 45 mm (satura­
tion studies) Nonspecific binding was defined as binding of 3H-TBOB in the 
presence of ΙΟ-1 M Picrotoxin 
The binding data were analyzed using computer assisted nonlinear regression 
analvsis methods 
RESULTS AND DISCUSSION. 
As the mteraction of folic acid with the Picrotoxin sensitive site seems to 
be of an allostenc nature (see below), we investigated the interaction between the 
three substances folic acid, GABA and TBOB by means of 3H-TBOB receptor bind­
ing studies in three different, partly complementary, settings keepmg the con­
centration of two compounds constant while varying the concentration of the 
third 
In the first setting the folic acid concentration was vaned at a constant 
3H-TBOB concentration of 4x10-' M and in the absence or presence of SxlO-6 M 
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or SxlO-3 M GABA (fig 1) Vanation of folic acid concentration produces a dose-
dependent enhancement of 3H-TBOB binding In the absence of GABA (control), 
SxlCM M folic acid produces an enhancement to (132 + 4) % (mean ± SEM, n=7 
fig 1, left ordinate) The enhancing potency of folic acid increases relatively in 
the presence of GABA In the presence of SxlO-6 M GABA, folic acid produces an 
enhancement to 190 % of initial binding (fig 1, 2nd ordinate, initial binding 70 % 
of control) In the presence of 5x10-' M GABA the enhancement is as high as 
380 % (at ΙΟ-3 M folic acid, fig 1, 3rd ordmate, initial binding Is 20 % of con­
trol) The effects of concentrations of folic acid m excess of ΙΟ- 3 M could not be 
determined due to limited solubility of the compound 
3 H TBOB binding (%of control) 
Fig 1 
Effect of varying the concentration 
of folic acid on 3H-TBOB binding 
(4xl0-9 M) m the absence 
( · leñ ordinate, is control) and 
m the presence of 5\10-6 M GABA 
( o ,middle ordinate initial binding 
is 70 % of control) and 5xl0-3 M 
GABA ( Δ ,nght ordinate initial 
binding is 20 % of control) (each 
data point is the mean of dupli­
cates, representative curves of 
three similar experiments) Note 
folic acid reverses the mhibitory 
effect of GABA on the binding of 
3H-TBOB 
о io5 ra" ioJ 
Folic acid (M) 
Hommes [4] demonstrated that the concentration of folic acid m the epilep­
togenic focus after intravenous injection of fobc acid (in rats) at the moment 
spikes become visible on the EEG, has a value of 1 SxlO-4 M The concentration 
range of folic acid that results m an enhancement of 3H-TBOB binding is thus in 
agreement with the result of these in vivo expenments 
Physiological concentrations of GABA are in the micromolar range Moreover 
GABA increases the CL - permeability at a concentration of around 10"' M [5] It 
is therefore reasonable to assume that the enhancement of 3H-TBOB binding by 
folic acid in the presence of + ΙΟ-5 M GABA can account for a pharmacologically 
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relevant response Effects of the same kind on 33S-TBPS binding were recently 
reported for some GABA antagonists [9] 
In the second setting the GABA concentration was varied at a constant 
3H-TBOB concentration of 4xl0-9 M and in the absence or presence of 5x10"* M 
folic acid (fig 2) GABA inhibits 3H-TBOB binding with an ICao of 
(55 + 0 3)xl0-6 M (mean ± SD, n-2) The enhancement of 3H-TBOB binding 
produced by folic acid can be reversed, since GABA inhibits the enhanced binding 
as well, but the potency of GABA in inhibiting the 3H-TBOB binding is reduced 
by folic acid the ICao of GABA increases threefold, ICao - (18 ± 8)xl0-6 M (n-2) 
fig 2 
Effect of varying the concentration 
of OABA on 3H-TBOB binding 
(4 nM) m the absence ( · ) and m 
the presence (O) of 5x10-* M 
folic acid (data points are the mean 
of duplicates, this result was 
replicated once) Note fohc acid 
enhances the ICso of OABA three­
fold 
In the third setting the 3H-TBOB concentration was vaned in the absence 
or presence of 5xl0-4 M folic acid, or SxlO-6 M GABA, or both (fig 3, binding 
parameters table 1) Folic acid produces an increase in the apparent number of 
binding sites In contrast the apparent affinity is unchanged The effect of GABA 
is found to be a reduction of the apparent number of binding sites, again without 
an effect on the affinity Incubation of the samples in the presence of both folic 
acid and GABA produces a parallel Scatchard plot as well Once again it is seen 
that the effects of folic acid and GABA are opposite to each other, which is 
shown in the first two settings as well 
H TBOB binding (pmol/g) 
Э 
о ю ю ю го" 10 
GABA(M) 
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Table 1 Binding parameters of 3H-TBOB m the absence and m the presence of 
folic acid or GABA, (mean ± SEM) 
Kd values are not signifícantlv different by paired Student t-test (p^O 05) 
Rt values do significantly differ from each other by paired Student t-test (p 0 01) 
compound 
control 
Folic acid 
GABA 
Ьх10-< 
bxlO-6 
M 
M 
η 
9 
9 
4 
Kd 
nM 
7.4 ί 0.8 
8.7 ± 0.9 
8.7 ± 1.3 
Rt 
pmol/g 
21 ± 2 
J4 ± 3 
12 ± 2 
bound/free (ml/g) 
Fig 3 
Scatchard analysis of 3H-TB0B 
binding m the absence of modulat­
ing agents ( φ ), m the presence of 
SxlO- M folic acid ( О ) m the 
presence of 5x10-* M OABA 
( ν )(representative curves of at 
least four similar results, see table) 
and m the presence of both 
Sx 10- M folic acid and 5x10-* M 
GABA (0) Note folic acid 
enhances the apparent Rt whereas 
GABA reduces it Combined addition 
of both agents results in an 
intermediate Rt value 25 30 3 5 
H TBOB bound (pmol/g) 
The enhancement of Ή-ΤΒΟΒ binding by folic acid may be interpreted as 
opposing GABA's binding-diminishing action In this way the dismhibitory proper­
ties of folic acid found m electrophysiological experiments [2,8] can be translated 
into terms of receptor binding studies Smce the membranes are washed once 
only, we might speculate that the enhancing effect of folic acid in the control 
situation might be due to the presence of some endogenous GABA 
The mechanism of this folic acid effect is clearly not picrotoxm like, ι e 
competitive with 3H-TBOB, but seems to be of an allostenc nature Further 
experanents are needed to elucidate the point of interaction of folic acid on the 
GABAA-receptor complex-Cl-ionophore 
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CONCLUSION. 
The presented results suggest that folic acid does indeed have an influence 
on the GABAA receptor complex, namely a modulation of the Picrotoxin sensitive 
site In doing so folic acid reverses the action of GABA The exact mechanism of 
this effect is still obscure 
It is tempting to assume that this biochemical effect might be a first step in 
the elucidation of the mechanism of folic acid induced epileptic phenomena 
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CHAPTERS 
A COMPARISON OF THE EFFECTS OF FOLIC ACID, 
BICUCULUNE AND ErHYL-ß-CARBOLINE-3-CARBOXYLATE 
ON »H-TBOB BINDING 
With the participation of 
J F Rodngues de Miranda, Τ J A M van der Velden, 
L· Willems-van Bree and O R Hommes 
SUMMARY. 
We compared folic acid with bicuculline and ethyl-ß-carbohne-3-carboxylate 
(ßCCE) m influencing the binding of the cage convulsant [3H]-t-butvlbicvcloor 
thobenzoate (3H TBOB) to rat brain membranes Folic acid (ΙΟ - 3 M to IO"3 M) 
enhances 3H-TBOB binding and reverses the inhibitory effect of GABA and 
diazepam, but not that of TBPS and Picrotoxin, on 3H-TBOB binding Bicuculline 
(10-a M to 10-» M), but not ßCCE, mimics the influence of folic acid on 3H-TBOB 
binding These findings support the hypothesis that seizures induced by folic acid 
and by bicuculline share a common biochemical mechanism 
INTRODUCTION 
Folic acid can evoke epileptic phenomena when it penetrates into the brain 
[20] The biochemical background of this action is unknown [6] A blockade of the 
inhibitory GABA response was found in electrophysiological experiments [22], 
suggesting an effect of folic acid on the GABAA receptor complex 
The GABAA receptor-complex is an oligomenc membrane protem with 
allostenc binding sites [1] Ligand binding assavs have demonstrated at least three 
distinct binding sites on the receptor complex GABA receptor sites (high- and 
low-affinity), benzodiazepine sites and picrotoxinin or convulsive sites [1] 3H-
TBÜB is thought to label a site closely related to the picrotoxinin binding site 
[27] 
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In the Chapters 6 and 7 we reported that folic acid reverses the action of 
GABA on 3H-TBUB binding [31) Presently we report that this action of folic 
acid resembles closely that of bicuculhne a GABAA antagonist [21], but not that 
of ethyl-ß-carboline 3-carboxvlaie (ßCCE) an inverse-agonist of benzodiazepine 
binding sites [3] 
METHODS. 
[3H]-t-butylbicycloorthobenzoate binding was performed according to 
Lawrence et al [9] See also chapter 5 PH-TBOB, specific activity 54 Ci/mmole) 
Homogenates of brains ot male Wistar rats (200 ± 20 g) were used Crude synaptic 
membranes (P2 fractions) were suspended in 0 05 M sodium-potassium-phosphate 
buffer, pH 7 4, containing 0 5 M NaCl The pellets were washed once onlv 
3H-TBOB (4 nM) was incubated in the absence or presence of fixed concentrations 
of GABA. diazepam, or TBPS, and varying concentrations of folic acid bicucullme 
or ßCCE Incubations were at 25 0C for 45 mm Nonspecific binding was defined 
as binding of 3H-TBOB in the presence of 10 μΜ Picrotoxin The binding data are 
given as the fraction of control binding, ι e the binding in the absence of anv 
modulating drugs 
The radioligand was obtained from Amersham, England The nonlabeled 
ligands were obtained from Sigma, England, except tor TBPS, which was delivered 
by NEN, Germany 
RESULTS. 
GABA (ІСзо 8 8 ± 1 5 μΜ, slope factor 1 07 ± 0 09), diazepam (ICso 24 ± 3 
μΜ, slope factor 0 66 ± 0 04) and TBPS (ICso 0 13 ± 0 02 μΜ, slope factor 1 12 ± 
0 04)(mean + SEM, n-4), displaced 3H-TBOB binding to rat brain membranes 
Folic acid and bicucullme both produced a dose dependent enhancement of 4 
nM 3H-TBOB binding, as is depicted in fig 1 (folic acid) and in fig 2 (bicucullme) 
In the absence of other drugs folic acid produced an enhancement to 143 + 5 % 
of control binding (mean + SD, n-20) at the highest concentration tested (1 mM), 
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whereas the enhancement bv 10 μΜ bicuculline reached 171 ± 10 % of control 
binding (n-8). ßCCE altered 3H-TBOB binding in a biphasic manner, reaching 125 ± 
5 % of control binding at 0.1 μΜ and 76 + 6 % at 10 μΜ (η - 4). 
Both folic acid and bicuculline reversed the inhibition of зН-ТВОВ binding 
by OABA as well as the inhibition by diazepam. The inhibition caused by 5 μΜ 
GABA was completely reversed, whereas the influence of 50 μΜ OABA (tested only 
with folic acid, data not shown) or with 50 μΜ diazepam was reversed only 
partially. (3CCE reversed neither the inhibition of OABA nor that of diazepam. 
The inhibition of 3H-TBOB by TBPS (a compound structurally related to 
TBOB) was not reversed by either of the tested ligands. 
Η TBOB binding (% ol control) 
•eo-
'60 
1Ί0 
1?0 
100 
80 
H-TBOB binding (% ol conirol) . л н TBOB binding (·<, ol conlral) , 
log folic acid (M) 
180 
160 
140 
120 
100-
8 0 -
6 0 -
10 
? 0 -
0 
В 7 6 5 
loq bicuculline (M) 
1 0 
160-
140-
120-
100 
80 
СО­
ЛО • 
20 
0 
logpCCE (M) 
Fig. 1 Fig. Fig. 
Fig. 1, 2. 3. 
Effect of varying the concentration of folic acid (fig.I), bicuculline (fig.2) and 
ßCCE (fig.3) on 3H-TBOB binding (4 nM) in the absence of any modulating agents 
( • ), in the presence of 5 μΜ GABA ( α ), ¡η the presence of 50 μΜ diazepam 
( • ) and ¡n the presence of 0.2 μΜ TBPS ( Δ ). 
Each data point is the mean of at least 4 measurements. The bars indicate JxSD. 
Note: the pattern of influence on the binding of the radioligand of folic acid 
resembles that of bicuculline. 
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DISCUSSION. 
3 H TBOB was only recently introduced as a probe for the GABAA receptor 
coupled Cl--channel Only a few reports for its interactions with the other 
binding sites of the ОАВАд-гесеріог complex are available yet [2, 9, 15, 26] As 
numerous reports on allostenc interactions of the 30S TB PS binding sites with the 
other sites of the GABAA complex are published [eg 4, 5, 7, 8, 32, 12, 13, 17, 
19, 24, 27, 28, 29 30] we compare our results to these although it is suggested 
that the compounds TBOB and TBPS may have slightly different influences on the 
ion channel [19, 23] The binding site of Picrotoxin is thought to be closely 
related to the recognition site(s) of TBOB and 1BPS [27] 
It is suggested that GABA and GABAergic enhancing ligands modulate the 
convulsant binding sites via an allostenc action In our membrane preparations, 
GABA and diazepam inhibit 3H-TBOB binding Some previous reports show an 
enhancement of 3!IS-TBPS binding bv diazepam [32, 17, 30] However, these studies 
used extensively washed membrane preparations It is assumed that displacement of 
"S-TBPS binding by diazepam is GABA dependent and that m GABA free prepara­
tions an enhancement of 3!1S-TBPS binding by diazepam is found [8] As our 
membranes are washed once only, the presence of endogenous GABA may account 
for the observed inhibition [8, 12, 13] Moreover, the enhancement of 3H-TBOB 
binding by bicucuUine and by folic acid m the absence of exogenous modulators 
are likely be due to unwashed endogenous GABA as well [33] 
frolic acid and bicucuUine reverse allostenc inhibition of 3H-TBOB binding 
but did not affect (competitive) inhibition by the convulsant TBPS Folic acid 
appeared to reverse the inhibitory effect of pentobarbital as well, but not that of 
Picrotoxin (data not shown, we have not tested this for bicuculhne but it has 
been reported for bicucuUine on 33S-TBPS binding in [10, 11]) These results 
suggest that folic acid and bicucuUine may affect in a similar way the GABAA 
receptor-complex This suggestion is supported by in vivo experiments When 
injected into the neocortex of the rat, folic acid produces epileptic phenomena 
which are m many respects similar to the syndrome mduced by bicucuUine 
methvlchlonde 
A number of convulsant drugs have been shown to reverse GABA inhibition 
of 3:lS-TBPS binding [7, 28] Some endogenous ammo acids, associated with seiz-
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ures, have this effect as well [29] It is suggested that the ability of a drug to 
reverse GABA's inhibitory effect on TBPS binding may predict convulsive effects 
[28] 
The pattern of reversing the inhibition of 3H-TBOB binding by folic acid and 
bicucullme is not mimicked by ßCCE The biphasic effect of ßCCE on control 
binding is in agreement with the results of reported functional experiments [25] 
GABA induced CI"- currents changed from 12 % inhibition at 0 1 μΜ ßCCE to 30 
% stimulation at 10 цМ 0ССЕ Other authors report an inhibition of 3 ! ,5-ГВРЗ 
binding [16, 18) or an enhancement of this binding [5] The lack of interaction 
between ßCCE and diazepam is somewhat surprising, as these hgands are thought 
to compete for the same receptor sites The concentrations of diazepam and ßCCE 
needed to produce their effects on the binding of 3Н-ГВОВ were above ΙΟ-7 M 
These concentrations do not correspond with the nanomolar affinities reported for 
binding to the high affinity central benzodiazepine receptor site [3, 14] This 
discrepancy pleads against an interaction of the nanomolar affinity benzodiazepine 
receptor sites (binding diazepam as well as ßCCE) with the 3H-TBOB sites 
CONCLUSION. 
The aim of this study was to mvestigate the biochemical mechanism of the 
convulsive action of fohc acid The present results support the hypothesis that 
fohc acid interacts with the GABAA-receptor complex The effect of folic acid on 
the binding of the cage-convulsant 3H-TBOB resembles that of bicucullme and not 
that of ßCCE This finding supports our suggestion of a common biochemical 
mechanism for bicucullme and folic acid Whether folic acid and bicuculhne share 
indeed a common bmding site remains to be elucidated 
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In the second part of thi4 thesis the m vitro imettigations concerning the 
biochemical mechanism tesponsible for the convulsive effect·! of folic acid have 
been described 
- The rank order of the potency of folates in causing epileptogenic effects 
was determined in vivo bv quantification of the seizures following ¡ntracor-
tical application m rats (ch 6) The tank order is 
folic acid > 5-НСО-ШоШе Hifolate ч 5-СНз-Hi folate 
- This sequence of epileptogemcitv was compared to the rank order of the 
effecti of folates on radioligand binding to the GABAA-receptor-complex m 
vitro (ch 6) Vo correlation of the strength of the epileptogenic effects of 
the folates with their mhibitorv potencies on 3 H muscimol binding (high 
affímtv GABA site) was observed, nor with the mhibitorv potencies on 3H-
dia¿ep<im bmdung (benzodiazepine 4ite) Folates reverse the inhibiting effect 
of GABA on the binding of3H-TBOB The rank order of this m vitro effect 
folic acid ï-HCO-Hifolate ·> Hifolate ~ 5-СНз-Н4оШе 
does correlate with the rank order of epileptogemcitv determined m vivo 
This result supports our hvpothesis that folic acid exerts Us epileptogenic action 
through an interaction with the GABAA receptor comple\ 
The nature of the ¡ntetaction of folic acid with the GABAA complex was inves-
tigated as well 
- The inhibitory effect of GABA and the reverse effect of folic acid on 3H-
TBOB binding were found to result from a modulation of the apparent 
number of 3H-TBOB binding sites rather than from a modulation of the 
apparent affimtv of the radioligand (ch 7) 
- Fmallv (ch ?) fohc acid not only reverses the mhibitorv action of GABA 
on
 3H TBOB binding but аію reverses that of diazepam The GABA antago­
nist bicuculhne mimics these actions of folic acid These observations will be 
further elaborated on m chapter 9 Conclusion 
87 
PROMENADE 3 NEDERLANDS 
in het tweede deel van dit proefschrift werden de m vitro experimenten betrei 
lende het epileptoeene werkingsmechanisme van foliumzuur beschreven 
- De mate waann de verschillende folaten epileptoeene effecten kunnen indu 
ceren werd eent m vivo bepaald door de aanvallen die optraden na intrd 
corticale injectie van de folaten te quantifíceren (hfdst 6) De rangorde is 
fohum zuur •· 5-HCO Ihfolaat s Hifolaat 5 СНз Hifolaat 
- Deze m vivo epileptogeniciteitsreeks werd vergeleken met de rangorde m 
vitro van effecten op de binding van radiohganden aan het GABAA receptor 
complex (hfdst 6) Tussen de sterkte van epüeptogemciteit m vivo enerzijds 
en het vermogen om de 3H muscimol bmdmg (hoge affiniteit GABA plaats) 
of de 3H diazepam bmdmg (benzodiazepine plaats) te verdringen anderzijds 
werd geen correlatie gevonden 
Folaten bleken de verdringing van 3H-TBOB (convulsive plaats) door GABA 
tegen te gaan De rangorde van dit m vitro effect 
foliumzuur S-HCO-Hrfolaat Hifolaat ~ S-CHo-Hifolaat 
correleert wel met de volgorde die m vivo gevonden werd 
Dit resultaat ondersteunt de hypothese dat door foliumzuur geïnduceerde epilepto 
gene verschijnselen veroorzaakt worden door een interactie van foliumzuur met 
het GABAA complex 
De aard van de interactie van foliumzuur met het GABAA complex werd eveneens 
onderzocht 
De verdringing van 3H-TBOB door GABA en het tegengestelde effect door 
foliumzuur bleken te komen door een verandering in het aantal receptoren 
zoals dat gemeten wordt en met door een verandering m de gemeten af-
finiteit van 3H TBOB voor zijn receptor (hfdst 7) 
- Tenslotte (hfdst 8) foliumzuur keert met alleen de verdnngmg door GABA 
om maar ook die van diazepam De GABA antagonist bicucullme heeft het 
zelfde effect als foliumzuur op de door GABA of diazepam verdrongen 3H-
TBOB bmdmg Op deze waarnemingen zalm de conclusie verder worden ingegaan 
CHAPTER 9 CONCLUSION 
In this thesis a causal relationship between the in vivo and the in vitro effects 
of folic acid is hypothesized We propose that the prevention of GABA induced 
inhibition of 3H-TBOB binding is the biochemical basis of the observed epileptic 
phenomena However a number of questions remam to be answered 
1) Is the site of interaction of folic acid with the GABAA complex 
the low affinity GABA site? 
From a pharmacological point of view it is reasonable that a drug (folic acid) 
which diminishes the action of an anticonvulsive compound (GABA) might have 
convulsive properties We therefore think it is plausible that our hypothesis holds 
true (i e the prevention of GABA induced inhibition of 3H-TBOB binding is the 
biochemical basis of the observed epileptic phenomena) 
The exact point of interaction of folic acid with the GABAA receptor complex 
remains to be elucidated however 
It is not likely that folic acid interacts with the nanomolar affinity GABA sites or 
with the (nanomolar afflmtv) benzodiazepine sites (ch 6) Another binding site 
must be involved GABA is thought to inhibit 3H-TBOB binding through an allo-
stenc interaction of the micromolar afflmtv GABA binding site with the convul-
sant site [15, 25, 28 ch 51 Question 1 originates from these considerations 
In favour of an affirmative answer would be the following considerations 
- Bicuculline is thought to bind to this low affinity GABA site [16. 21] 
- When injected into the neocortex folic acid is mimicked by bicuculline 
(ch 1) 
- Folate modulation of эН-ТВОВ binding in vitro is mimicked by bicuculline 
(ch 8) 
On the other hand however 
When injected mto the prepmform cortex, folic acid does not mimic the 
action of bicuculline (ch 4), so an exactly similar mechanism of action is 
not likely 
Competition studies using radiolabeled hgands with high selectivity and sufficient 
affinity for the GABAA low affimtv binding sites (e g 3H-bicuculline (Kd-40 nM) 
[21], or 3H-SR 95531 (K<i= 8 nM) [10]) will be necessary to answer the question 
whether folates bind to the low affimtv GABA site [16] 
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2) Is there а ОАВАл receptor heterogeneity for the interaction with 
either folates or bicucuHine? 
A vanetv of chemicallv diverse compounds has been shown to reverse OABA 
inhibition of «S-TBPS binding [3 5 12 22 27 28 29] analogous to our descnp 
tion of folate effects on 3H-TBOB binding (ch 6) Modulatorv sites on the GABA 
complex conducting these effects have been postulated [25] 
Assuming the interaction of the folates with a modulatorv site it is tempting to 
assume that there are regional differences in the effects of the GABA modulators, 
resulting eg from a different expression of GABAA receptor units [14 23] Such 
regional functional differences have been postulated before for the benzodiazepine 
sites on the complex [4 13 19 20 26] This was a great stimulus in the search 
for compounds with disease specific activities, lacking the global sedating proper 
ties of the classical benzodiazepines [2 6, 8 19] An investigation of the postu­
lated regional differences of the modulatorv site may be of importance in the 
search for disease-specific drugs for two reasons 
- Manv of the reported modulators of the convulsant binding site are common-
Iv used clinical drugs (antidepressants antipsychotics, antihistaminics and 
compounds such as caffeine, theophylline) 
- bolate deficiency is associated with a vanetv of neuro-psvchiatnc disturban­
ces (depression psvchosis and dementia [1]) 
3) What mechanism can explain the changes In the number of 
э
Н-ТВОВ binding sites m the presence of GABA or folic acid? 
In chapter 7 we showed that folic acid reverses the GABA induced inhibition of 
3H-TBOB binding m displacement assays In saturation assays, the effect of GABA 
inhibition of эН-ТВОВ binding appears to be a reduction of the apparent number 
of binding sites (i e a decrease in Rt), whereas the effect of folic acid appears to 
be the reverse Question 3 anses from theoretical considerations For reversible 
hgand-receptor systems a change in Rt is hard to explain [11 30] A reduction in 
Rt can only anse from irreversible processes [31] GABA-receptor binding is not 
likely to be an irreversible process ^o, the apparent reduction of Rt may be due 
either to a misinterpretation of the data or to quasi irreversible processes [24] 
A recent indication for the occurrence of a misinterpretation is given bv Maksay 
and coworkers They showed that GABA and GABAergic enhancing agents ac-
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celerate the dissociation rate of TBPS [17. 18] Interconvertable populations of 
convulsant sites with rapid and slow (dissociation) kinetics are proposed [17] An 
increase in the population of the rapid phase might be brought about by G\BAer-
gic enhancing drugs, and the reverse by GABAergic inhibitory compounds 
In our binding assavs we might have measured the high affinity sites only and 
may have missed the low affinity population the highest concentrations 3H 1BOB 
used were usually about 30 nM too low to measure Kd values in excess of 15 nM 
[9, 33] Moreover, we used the filtration technique which is generally not suitable 
for measuring low affinity sites [33] Saturation experiments over a wide range of 
radioligand concentrations (the availability of the unlabeled TBOB makes this 
suggestion economically feasible) combined with centrifuge techniques would be 
necessary to elucidate the low affinity population 
4) What Is the nature of the benzodiazepine interactions with 
aH-TBOB binding? 
In chapter 8 we showed that folic acid and bicuculline reverse not only the action 
of GABA on 3H-TBOB binding but also that of diazepam In contrast ßCCb does 
not reverse the inhibition of 'H-TBOB by diazepam The lack of interaction 
between ßCCE and diazepam is somewhat surpnsing, as these ligands have op-
posite effects in vivo and are thought to compete for the same receptor sites 
[6] It is reported that β carbolines may produce their effects independently of 
GABA, whereas diazepam effects are GABA dependent A different coupling of the 
binding sites of these two substances to the Cl--channel is proposed Moreover 
the concentrations of diazepam and ßCCb needed to produce their effects on the 
binding of 3H-TBOB are in excess of 100 nM These concentrations do not coin-
cide with the reported nanomolar affinities for binding to the 'central' benzodia-
zepine receptor site This discrepancy pleads against an interaction of the nano-
molar affinity 'central' benzodiazepine receptor sites with the 3H-TBOB sites 
The inverse agonist, the convulsant benzodiazepine Cl-diazepam (Ro 5-4864) is re-
ported to partially reverse the action of GABA on TBPS binding as well [7] This 
compound has a high affinity for the 'penferal type' of the benzodiazepine 
receptors [32] Companson of the effects of this ligand to those of the tested 
compounds described in this thesis may be of help in the investigation of the 
relationship between benzodiazepine sites and convulsant sites 
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STRUCTURAL FORMULAE OF THE MOST IMPORTANT COMPOUNDS 
1 FOLIC ACID 
^N 
ΛΛ . С — Л/ 
. C-/V-C-C, 
ομ 
С 
'с f 
ОН 
(1) 
GABAA RECEPTOR COMPLEX 
site 
Agonists 
Antagonist 
,
0
" 
2 GAB A ^N-\
c
^-
(2) 
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Stuctural Formulae 
GABAA RECEPTOR (continued) 
Depressant sice: 
Agonist 10: Pentobarbital 
GABAB RECEPTOR 
Agonist 11: Baclofen 
GLYaNE RECEPTOR 
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^ с , 
CU i 
/ OH 
"'Ч- ^ 
-ci 
(10) 
( И ) 
Agonist 12. Glycine 
Antagonist 13. Strychnine 
«,// / 
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(12) 
α 
(13) 
GLUTAMATE RECEPTOR 
Agonists 14: Glutamic Acid 
15: Kaimc Acid 
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c -
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( U ) 
(15) 
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FOLDER ОАВАл RECEPTOR COMPLEX 
Q-Ion channel 
Benzodiazepine site: 
Agonist | 
Diazepam 
Invene agonist } 
ßCCE 
Convulsant site: 
Agonists | 
TBOB 
TBPS 
Picrotoxinin 
QABA aite: . 
Agonists I GABA 
Muscimol 
Antagonist I Bicuculline 
^—Depressant site: 
Agonists | 
Barbiturates 
Membrane Interactions: 
Steroids ι 
Alcohol 
Noncompetitive Inhibitors 
of other Receptors: | 
Phencycüdine 
D-Tubocurarine 
Schematic model of the ОАВАл complex. 
Arrows indicate the enhancement (\) or the inhibition (\) 
of QABAergic function by the various agents. 
(Reproduced (modified) from R.D. Schwartz, 
Biochem. Pharmacol., 37 (1988) 3396-3375, with permission) 
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2 De waarneming, dat GABA-agonisten niet alleen de dissociatiesnelheid maar ook de associa-
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complex, wijst erop dat de vooronderstelling, dat de associatiesnelheid alleen afhankelijk is 
van diffusieprocessen niet juist is. 
Maksay, G., and Simonyi, M.. Mol. Pharmac, 30 (1986) 321-32S. 
3 Hoewel moeilijk te bewijzen is, dat de bij knaagdieren spontaan optredende piek-golf 
complexen epileptisch van aard zijn, kunnen dieren met deze verschijnselen goed gebruikt 
worden als een model voor mensen met absence epilepsie. 
Kaplan, B.J., Exp. Neurol., SS (1985) 425-436. 
Marescaux, С. et al. Epilepsia. 25 (1984) 326-331. 
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4 Muscimol heeft een uitgesproken anticonvulsieve werking bij chemisch geïnduceerde focale 
epilepsie in de rat, ongeacht of deze convulsies geïnduceerd worden door disinhiberende 
stoffen of door direct exciterende stoffen. 
Van Rijn et al. in voorbereiding. 
5 De waarneming dat potentiëring van de inhibitie bij een diermodel voor absence epilepsie 
het aantal piek-golf complexen per tijdseenheid doet toenemen, terwijl dit bij een diermodel 
voor focale, convulsieve epilepsie een antiepileptische werking heeft, doet vermoeden dat er 
een fundamenteel verschil bestaat tussen convulsieve en niet-convulsieve epilepsieën. 
Myslobodsky. M.S., In R.G. Fanello et al. Neurotransmitters, Seizures and Epilepsy IL 
Raven Press. New York. (¡984) 337-345. 
6 De observatie dat benzodiazepine- agonisten zowel convulsieve epilepsie als absence epilepsie 
onderdrukken doet vermoeden, dat bij de werking van benzodiazepinen meerdere receptoren 
betrokken zijn. 
Schoemaker, H, et al.. Eur. J. Pharmacol, 7¡ (¡981) 173-175. 
7 Het werkingsmechanisme van een epilepsie beïnvloedend farmacum hoeft niet noodzakelij-
kerwijze waardevolle aanwijzingen op te leveren omtrent het mechanisme, dat ten grondslag 
ligt aan de spontaan optredende epilepsie. 
Bradford, H.F. and Peterson, D.W., Molec. Aspects Med. 9 (¡987) 119 172. 
8 Om de effecten van een psycho-actieve stof te bestuderen, kan niet volstaan worden met 
het beoordelen van het alleen het EEG; gedragsobservaties zijn hierbij ook noodzakelijk. 
Coenen. A.M.L. and Van Luijtelaar. E.L.J.M.. Proc. WASAR-Meeting, Bazel ¡9S9. 
9 Het valt zeer te betreuren, dat waar sportcompetities integraal op de televisie worden 
uitgezonden, internationale muziekconcoursen het op dit medium veelal met een korte 
samenvatting moeten stellen. 
10 De hoge tempi, tegenwoordig in de mode bij uitvoeringen van barokmuziek, gaan vaak te 
zeer ten koste van toonvorming en expressie. 
11 Het gebruik van de zinledige term 'chemische stof kan er toe leiden, dat de schadelijke 
werkingen van niet als zodanig aangeduide stoffen ten onrechte onderschat worden. 
Tineke van Rijn, 22 juni 1989. 



